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Abstract		
	
A	ligand	skeleton	combining	a	1,10-phenantholine	(phen)	binding	site	and	one	or	two	
heptadentate	N3O4	aminocarboxylate	binding	sites,	connected	via	alkyne	spacers	to	the	
phen	C3	or	C3/C8	positions,	has	been	used	to	prepare	a	range	of	heteronuclear	Ru•M	and	
Ru•M2	complexes	which	have	been	evaluated	for	their	cell	imaging,	relaxivity,	and	
photophysical	properties.		In	all	cases	the	phen	unit	is	bound	to	a	{Ru(bipy)2}2+	unit	to	give	a	
phosphorescent	{Ru(bipy)2(phen)}2+	luminophore,	and	the	pendant	aminocarboxylate	sites	
are	occupied	by	a	secondary	metal	ion	M	which	is	either	lanthanide	[Gd(III),	Nd(III),	Yb(III)]	
or	another	d-block	ion	[Zn(II),	Mn(II)].		When	M	=	Gd(III)	or	Mn(II)	these	ions	provide	the	
complexes	with	a	high	relaxivity	for	water;	in	the	case	of	Ru•Gd	and	Ru•Gd2	the	
combination	of	high	water	relaxivity	and	3MLCT	phosphorescence	from	the	Ru(II)	unit	
provide	the	possibility	of	two	different	types	of	imaging	modality	in	a	single	molecular	
probe.		In	the	case	of	Ru•Mn	and	Ru•Mn2	the	Ru(II)-based	phosphorescence	is	substantially	
reduced	compared	to	the	control	complexes	Ru•Zn	and	Ru•Zn2	due	to	the	quenching	effect	
of	the	Mn(II)	centres.		Ultrafast	transient	absorption	spectroscopy	studies	on	Ru•Mn	(and	
Ru•Zn	as	a	non-quenched	control)	reveal	the	occurrence	of	fast	(<	1	ns)	PET	in	Ru•Mn,	from	
the	Mn(II)	ion	to	the	Ru(II)-based	3MLCT	state,	i.e.	MnII–(phen•–)–RuIII	®	MnIII–(phen•–)–RuII;	
the	resulting	MnIII–(phen•–)	state	decays	with	t	≈	5	ns	and	is	non-luminescent.		This	occurs	in	
conformers	when	an	ET	pathway	is	facilitated	by	a	planar,	conjugated	bridging	ligand	
conformation	connecting	the	two	units	across	the	alkyne	bridge	but	does	not	occur	in	
conformers	where	the	two	units	are	electronically	decoupled	by	a	twisted	conformation	of	
the	bridging	ligand.		Computational	studies	(DFT)	on	Ru•Mn	confirmed	both	the	occurrence	
of	the	PET	quenching	pathway	and	its	dependence	on	molecular	conformation.		In	the	
complexes	Ru•Ln	and	Ru•Ln2	(Ln	=	Nd,	Yb),	sensitised	near-infrared	luminescence	from	
Nd(III)	or	Yb(III)	is	observed	following	photoinduced	energy-transfer	from	the	Ru(II)	core,	
with	Ru®Nd	energy-transfer	being	faster	than	Ru®Yb	energy-transfer	due	to	the	higher	
density	of	energy-accepting	states	on	Nd(III).	
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Introduction	
The	combination	of	transition	metal	and	lanthanide	ions	in	a	single	molecular	
complex	(d/f	complexes)	has	provided	interesting	opportunities	arising	from	the	
combination	of	metal	centres	with	substantially	different	structural,	photophysical	and	
magnetic	properties.1-4	Particular	properties	of	d/f	complexes	that	have	attracted	interest	
are	the	ability	to	combine	blue	[from	Ir(III)]	and	red	[from	Eu(III)]	luminescence	to	generate	
white	light;2	fundamental	studies	of	d®f	photoinduced	energy-transfer	(PEnT)	including	the	
use	of	d-block	chromophores	to	act	as	antenna	for	sensitisation	of	near-IR	lanthanide	
luminescence;3	and	the	combination	of	a	luminescent	d-block	unit	with	a	highly	
paramagnetic	lanthanide,	usually	Gd(III),	for	preparation	of	dual-modal	imaging	agents	
which	permit	both	luminescence-based	visualisation	of	cells	and	magnetic	resonance	
imaging	based	analysis	on	a	larger	length	scale	using	a	single	probe	molecule.4	
We	have	recently	investigated	d/f	complexes	based	on	ligand	skeletons	combining	a	
diimine-type	unit	[based	on	2,2’-bipyridyl	(bipy)	or	1,10-phenanthroline	(phen)]	coordinated	
to	a	d-block	centre	to	enable	absorbance	in	the	visible	range	due	to	metal-to-ligand	charge-
transfer	transitions,	with	a	polyaminocarboxylate	unit	that	provides	high	kinetic	and	
thermodynamic	stability	when	complexed	to	lanthanide(III)	ions.5,6	These	Ir/Ln	complexes	
(Scheme	1)	demonstrated	the	ability	to	combine	effective	luminescence	imaging	of	HeLa	
and	MCF7	cells,	including	two-photon	phosphorescence	lifetime	imaging	of	local	O2	
concentration,	with	high	relaxivity	for	the	Gd(III)	units	associated	with	the	rigidity	of	the	
assembly	which	comes	from	the	ligand	design.6	However,	there	were	clearly	solubility	
limitations	arising	from	the	hydrophobicity	of	the	central	Ir(III)	core	which	carries	a	charge	
of	only	+1.	
In	this	paper	we	develop	the	work	using	this	ligand	system	in	two	new	directions.	
Firstly	we	have	used	a	Ru(II)	tris-diimine	unit	as	the	d-block	luminophore,	given	its	excellent	
promise	as	a	component	of	water-soluble,	non-toxic	agents	for	optical	microscopy,7	and	its	
higher	charge	compared	to	the	cyclometallated	Ir(III)	centre	(+2	vs.	+1)	which	should	aid	
water	solubility.	We	have	combined	this	with	a	range	of	lanthanide	ions	including	Gd(III)	(for	
its	relaxivity	properties)	and	Yb(III)/Nd(III)	(for	the	possibility	of	sensitised	near-IR	
luminescence).	Secondly,	we	have	used	the	pendant	heptadentate	polyaminocarboxylate	
unit	as	a	ligand	for	complexing	additional	transition	metal	ions	as	well	as	just	lanthanide(III)	
ions	–	creating	the	possibility	to	form	d/d	as	well	as	d/f	assemblies,	in	which	ultrafast	
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spectroscopy	studies	have	been	used	to	investigate	intramolecular	photoinduced	electron	
transfer	from	Mn(II)	to	the	Ru-based	3MLCT	state	in	the	Ru/Mn	dyad.	
	
Results	and	Discussion	
	
(i)	Synthesis	and	characterisation.			
	
Mononuclear	Ru(II)	complexes.		
The	synthetic	strategy	is	summarised	in	Schemes	2	–	4	and	is	similar	to	the	approach	
we	used	for	the	previously-reported	Ir/Ln	complexes6	except	that	the	key	Sonogashira	
coupling	step,	connecting	the	polyaminocarboxylate	and	phenanthroline	units,	was	
performed	with	the	phenanthroline	unit	already	coordinated	to	the	Ru(II)	ion:	this	type	of	
‘chemistry	on	the	complex’	approach	has	been	used	by	others.8	We	found	that	the	coupling	
worked	better	if	we	exchanged	the	positions	of	the	relevant	functional	groups	from	those	
used	previously,6	such	that	the	reactive	Br	substituent	is	attached	to	the	Ru(II)	complex	core	
as	a	3-Br-phen	or	3,8-Br2-phen	ligand,	and	the	terminal	alkyne	is	pendant	from	the	
protected	polyaminocarboxylate	unit.	
	 The	complex	[Ru(bipy)2(Br-phen)](PF6)2,	A	(Scheme	2),8a	was	prepared	by	reaction	of	
3-Br-phen9	with	[Ru(bipy)2Cl2]•2H2O.	The	alkyne-containing	coupling	partner	compound	C	
(Scheme	3)	required	a	five-step	synthesis,	some	of	these	being	in	the	literature.	At	first,	
commercially	available	4-hydroxy-2,6-dimethylpyridine	was	brominated	at	the	4-position	
using	PBr5.10	The	two	methyl	groups	were	then	converted	to	–CH2Br	groups	using	radical	
bromination	with	N-bromosuccinimide	to	give	4-bromo-2,6-bis(bromomethyl)pyridine.11	
Installation	of	the	tert-butyl	protected	pendant	arms	of	the	metal	chelating	fragments	to	
give	the	known	intermediate	B12	was	achieved	through	a	substitution	reaction	with	two	
equivalents	of	di-(tert-butyl)-iminodiacetate,	and	then	a	straightforward	Sonogashira	
reaction	with	trimethylsilylacetylene	(TMSA)	introduced	the	trimethylsilyl-protected	alkyne	
group	at	the	4-position	of	the	pyridine	ring	(compound	CSi,	Scheme	3).	Deprotection	of	the	
trimethylsilyl	group	to	reveal	the	free	alkyne	C	was	carried	out	in	THF	using	tetra-n-
butylammonium	fluoride	(TBAF),	but	as	this	deprotection	was	performed	in	situ	before	
immediate	further	reaction	of	compound	C,	no	characterisation	data	were	recorded	for	this	
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intermediate	species;	attempts	to	isolate	analytically	pure	C	were	unsuccessful	and	tended	
to	afford	the	Glaser-coupled	di-alkyne	bridged	dimer.			
Components	A	and	C	were	then	combined	using	a	Sonogashira	coupling	using	Cu(I)	/	
Pd(dppf)Cl2	as	catalyst	in	anhydrous	DMF	/	diisopropylamine	(5:1,	v/v)	as	solvent	under	
argon,	affording	the	protected	Ru(II)	complex	Ru•E	in	50	%	yield	(Scheme	2;	‘E’	indicates	the	
presence	of	the	ester	protecting	groups	at	the	secondary	binding	site).	Satisfactory	
characterisation	was	provided	by	1H	NMR	spectroscopy	and	high-resolution	electrospray	
mass	spectrometry	(SI,	Figs.	S1	and	S2).	In	particular	at	lower	chemical	shifts	in	the	1H	NMR	
spectrum	there	are	singlet	peaks	at	1.45	ppm,	3.49	ppm	and	4.00	ppm	integrating	as	36,	8	
and	4	protons,	respectively,	which	represent	the	aliphatic	protons	on	the	pendant	arms	of	
the	protected	secondary	binding	site	formed	from	the	two	imino-diacetate	units.	Finally,	
removal	of	the	tert-butyl	protecting	groups	was	effected	by	prolonged	stirring	of	Ru•E	with	
excess	trifluoroacetic	acid	in	CH2Cl2	to	afford	Ru•L	(where	‘L’	denotes	the	deprotected	
secondary	ligand	site).		Again,	satisfactory	characterisation	was	provided	by	1H	NMR	
spectroscopy	and	a	high-resolution	ES	mass	spectrum	(SI,	Figs.	S3	and	S4),	with	the	1H	NMR	
spectrum	confirming	complete	loss	of	the	protons	from	the	tBu	groups	(previously	at	1.45	
ppm).	A	500	MHz	COSY	spectrum	was	used	to	confirm	the	1H	NMR	assignments.	
A	similar	method	was	used	to	prepare	the	scaffold	for	the	potentially	trinuclear	
complexes	in	which	there	two	are	two	identical	aminocarboxylate	binding	sites	pendant	
from	the	phen	ligand	on	the	central	Ru(II)	unit	(Scheme	4).	In	this	case	the	Ru(II)-based	
starting	complex	[Ru(bipy)2(Br2-phen)](PF6)2	(complex	D)	has	Br	substituents	at	both	
positions	C3	and	C8	of	the	phen	ligand.		Sonogashira	coupling	of	D	with	two	equivalents	of	C,	
under	similar	conditions	to	those	described	above	but	with	a	longer	reaction	time,	afforded	
complex	Ru•E2	–	with	two	ester-protected	heptadentate	binding	sites	on	either	side	of	the	
phen	ligand	–	in	45	%	yield	(SI,	Fig	S5	and	S6).	The	higher	(twofold)	symmetry	compared	to	
Ru•E	affords	a	simpler	1H	NMR	spectrum	with	the	aliphatic	signals	arising	from	the	
protected	polyaminocarboxylate	arms	at	1.45	ppm,	3.49	ppm	and	3.99	ppm	(Fig.	S5)	having	
integrals	consistent	with	the	expected	72:16:8	ratio	of	protons.	Removal	of	the	ester	groups	
using	the	same	method	as	described	above	(TFA	in	CH2Cl2)	afforded	the	deprotected	
complex	ligand	Ru•L2	with	two	pendant	binding	sites.	The	1H	NMR	spectrum	of	this	
compound	in	D2O	(SI,	Fig.	S7)	was	noticeably	broader	and	less	well	defined	than	the	
protected	form	Ru•E2	possibly	due	to	a	combination	of	the	size	of	the	complex,	the	viscosity	
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of	the	solvent,	and	strong	hydrogen-bonding	interactions	between	solute	and	solvent	which	
results	in	slow	tumbling	in	solution.	The	number	of	signals	and	their	relative	integrals	are	
correct,	and	a	high-resolution	ES	mass	spectrum	(SI,	Fig,	S8)	confirms	formulation	of	the	
complex.	
	
Heteronuclear	Ru•Ln	and	Ru•Ln2	complexes	(Ln	=	Gd,	Nd,	Yb).			
There	are	two	particular	reasons	for	studying	Ru(II)/Ln(III)	(‘Ln’	=	a	generic	
lanthanide)	complexes	based	on	this	ligand	skeleton.	The	first	is	that	incorporation	of	Gd(III)	
ions	allows	preparation	of	potential	dual-modal	imaging	agents	based	on	the	combination	
of	luminescence	plus	magnetic	resonance	imaging	with	the	same	probe.4,6		The	second	is	
that	incorporation	of	the	near-IR	emitting	lanthanide	ions	Nd(III)	and	Yb(III)	allows	the	study	
of	sensitised	emission	arising	from	d®f	PEnT.3	In	both	cases	the	fully	conjugated,	
unsaturated	structure	of	the	bridging	ligand	facilitates	the	desired	use;	the	structural	rigidity	
will	help	to	minimise	the	rotational	correlation	time	of	the	Gd(III)	centres	which	contributes	
to	high	relaxivity,13	and	the	electronic	conjugated	pathway	directly	connecting	both	Ru(II)	
and	Ln(III)	centres	will	facilitate	Dexter-type	PEnT	which	requires	through-bond	electronic	
coupling.6		The	varying	sizes	of	the	lanthanide	ions	used	mean	that	the	heptadentate	ligand	
will	be	supplemented	by	most	likely	1	or	2	water	molecules	depending	on	ionic	radius.		
	 Dinuclear	Ru•Gd	was	prepared	in	84%	yield	simply	by	stirring	1.1	equivalents	of	
GdCl3•6H2O	with	Ru•L	in	water	(pH	5	–	6)	for	18	h.	Size-exclusion	chromatography	on	
Sephadex	LH-20	in	MeOH,	followed	by	anion	metathesis	using	Dowex	1x2	chloride	resin	to	
ensure	that	all	hexafluorophosphate	anions	(from	the	starting	Ru(II)	complex)	were	replaced	
by	chloride,	afforded	pure	Ru•Gd	as	its	mono-chloride	salt.	Trinuclear	Ru•Gd2	was	prepared	
similarly	in	69	%	yield	from	Ru•L2	and	2.6	equivalents	of	GdCl3•6H2O	in	aqueous	solution.	
The	complex	Ru•Gd2	is	neutral	so	no	anion-exchange	step	was	necessary,	but	was	likewise	
purified	using	Sephadex	LH-20	eluting	with	MeOH.	Given	that	routine	characterisation	by	1H	
NMR	spectroscopy	was	not	feasible	for	these	complexes	due	to	extensive	paramagnetic	
line-broadening	by	the	Gd(III)	ions,	we	rely	on	a	combination	of	chromatographic	purity	and	
high-resolution	mass	spectra	(SI,	Fig.	S9	and	S10),	which	for	both	complexes	give	excellent	
agreement	with	expected	values	as	well	as	the	correct	isotopic	patterns.	
	 The	heteronuclear	complexes	Ru•Nd,	Ru•Nd2,	Ru•Yb	and	Ru•Yb2	were	synthesised	
in	high	yields	in	the	same	manner	as	the	analogous	Ru/Gd	complexes,	by	reaction	of	the	
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starting	‘complex	ligands’	Ru•L	and	Ru•L2	with	excess	(1.6	equivalents	or	2.8	equivalents,	
respectively)	of	the	appropriate	lanthanide	triflate	salt	in	water	at	pH	5	–	6.	The	dinuclear	
complexes	Ru•Nd	and	Ru•Yb	were	anion-exchanged	to	the	chloride	salts	using	Dowex®	1x2	
chloride	ion-exchange	resin	and	finally	purified	by	size-exclusion	chromatography	on	
Sephadex®	G-15	in	water.	The	trinuclear	complexes	Ru•Nd2	and	Ru•Yb2	are	neutral	so	
required	no	ion-exchange.	As	with	the	Ru/Gd	complexes,	high	resolution	ES	mass	
spectrometry	of	these	paramagnetic	complexes	confirmed	their	formulation	(SI,	Figs	S11	–	
S14).	
	
Heteronuclear	Ru•M	and	Ru•M2	complexes	(M	=	Mn,	Zn).			
Having	used	Gd(III)	ions	to	prepare	Ru•Gd	and	Ru•Gd2	as	described	above,	we	were	
interested	to	try	other	highly	paramagnetic	ions	in	these	sites	for	possible	alternative	dual-
modal	imaging	agents.	Recently,	interest	in	utilising	high-spin	Mn(II)	ions	as	alternative	
paramagnetic	centres	to	Gd(III)	in	T1-weighted	MRI	contrast	agents	has	grown,14,15	due	to	
increasing	concern	for	the	in	vivo	toxicity	of	free	Gd(III)	ions.	New	ligand	structures	are	
beginning	to	be	explored	to	incorporate	Mn(II)	into	probes	used	for	MR	imaging	purposes.14		
However,	examples	of	dual-modal	luminescence/MRI	probes	containing	Mn(II)	as	the	
paramagnetic	centres	are	rare,	with	only	one	recent	example	of	MnO2	nanosheets	
combined	with	[Ru(bipy)3](PF6)2	units	being	reported.15		Accordingly	our	ligand	skeletons	
were	also	used	to	prepare	Ru(II)/Mn(II)	complexes	to	examine	their	luminescence	and	
magnetic	relaxivity	properties;	the	analogous	Ru(II)/Zn(II)	complexes	were	also	prepared	for	
control	experiments.			
Dinuclear	complexes	Ru•Mn	and	Ru•Zn	were	prepared	by	reaction	of	Ru•L	with	1.3	
–	1.6	equivalents	of	the	appropriate	M(II)	chloride	hydrate	(M	=	Mn,	Zn)	for	18	h	in	water	at	
pH	5	–	6.	The	excess	metal	salt	was	removed	by	size-exclusion	chromatography	on	
Sephadex®	G-15	in	water	to	produce	the	pure,	neutral	compounds	in	good	yields	(80-95	%).	
As	Zn(II)	is	diamagnetic,	the	successful	synthesis	and	isolation	of	pure	Ru•Zn	was	confirmed	
by	1H	NMR	spectroscopy	(SI,	Fig.	S15).	The	signals	in	the	aromatic	region	of	the	1H	NMR	
spectrum	(400	MHz,	D2O)	integrate	to	the	expected	twenty-five	protons,	although	there	are	
four	singlets	at	δ	=	7.52	ppm,	7.54	ppm,	8.76	ppm	and	8.79	ppm	that	each	integrate	to	half	
a	proton.	A	two-dimensional	1H-1H	NMR	correlation	spectrum	confirmed	that	these	peaks	
correspond	to	either	a	pyridyl	H3/H5	pyridine	proton	(δ	=	7.52	ppm	and	7.54	ppm)	and	the	
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H2	phenanthroline	proton	(δ	=	8.76	ppm	and	8.79	ppm).	These	half-integral	values	suggest	
the	presence	of	two	isomers	in	solution,	which	were	not	present	in	the	1H	NMR	spectrum	
(d6-DMSO,	500	MHz)	of	the	starting	complex	Ru•L.	As	the	protons	in	question	are	only	split	
into	inequivalent	‘halves’	in	Ru•Zn,	it	would	suggest	that	the	two	isomers	are	brought	about	
by	the	chelation	of	the	Zn(II)	ion	at	the	polyaminocarboxylate	binding	site	to	generate	a	
chiral	centre,	and	are	therefore	diastereoisomers	arising	from	the	presence	of	two	chiral	
centres	close	together	–	the	other	chiral	centre	being	of	course	the	Ru(II)	tris-chelate	unit.	
This	suggestion	is	supported	by	the	appearance	of	a	multiplet	at	δ	=	3.34-3.52	ppm	in	the	1H	
NMR	spectrum	for	Ru•Zn,	which	integrates	as	eight	protons,	and	represents	the	four	CH2	
groups	adjacent	to	the	carboxylate	groups	of	the	secondary	metal	chelate	site.	In	the	1H	
NMR	spectrum	of	Ru•L	these	8	protons	are	equivalent,	occurring	as	a	singlet	at	δ	=	3.94	
ppm.		However,	once	the	Zn(II)	ion	is	bound	in	Ru•Zn,	they	become	inequivalent	and	appear	
as	a	multiplet	due	to	the	presence	of	the	diastereoisomers.	The	remaining	signal	in	the	
aliphatic	region	of	the	1H	NMR	spectrum	is	from	the	two	CH2	groups	attached	to	C2	and	C6	of	
the	pyridine	ring	(δ	=	4.15	ppm).	We	could	not	obtain	meaningful	1H	NMR	spectra	for	
Ru•Mn,	but	both	complexes	were	characterised	by	high-resolution	ES	mass	spectrometry	
(SI,	Figs.	S16	and	S17).		We	note	that	seven	coordination	is	known	for	in	some	Mn(II)	
complexes,	and	is	supported	by	the	calculations	(see	later).16		There	are	also	a	few	examples	
of	Zn(II)	complexes	with	seven-fold	coordination	despite	the	smaller	ionic	radius	of	Zn(II):	
these	generally	have	two	small	bidentate	nitrate	ligands.17	
	 Trinuclear	Ru•Zn2	and	Ru•Mn2	were	prepared	similarly	from	Ru•L2	and	excess	(2.4	–	
4.8	equivalents)	of	the	appropriate	M(II)	chloride	hydrate	(M	=	Mn,	Zn),	and	were	obtained	
in	good	yields	of	67	–	82	%.	These	are	dianionic	complexes	with	Na+	as	the	counter-cation.	
Ru•Zn2	could	be	characterised	by	1H	NMR	spectroscopy	(SI,	Fig.	S18)	and	gives	the	correct	
number	of	signals	in	the	aromatic	and	aliphatic	regions	which	integrate	to	the	required	
total:	the	spectrum	is	noticeably	broader	than	that	of	Ru•Zn,	likely	due	to	slower	tumbling	
in	solution	because	of	its	size	and	the	viscosity	of	D2O	(similar	to	the	difference	that	we	
observed	between	Ru•L	and	Ru•L2).	As	with	Ru•Zn	there	is	evidence	that	the	presence	of	
diastereoisomers	arising	from	the	presence	of	three	chiral	centres	splits	some	signals	into	
several	components.	For	example,	the	singlet	at	δ	=	7.69	ppm	for	the	four	pyridyl	H3/H5	
protons	in	Ru•L2	is	split	into	two	broad	singlets	between	7.50	and	7.70	ppm	in	the	spectrum	
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of	Ru•Zn2.	High	resolution	ES	mass	spectra	confirmed	the	formulations	of	Ru•Zn2	and	
Ru•Mn2	(Figs.	S19,	S20).	
	
(ii)	Photophysical	properties.			
	
Mononuclear	Ru(II)	complexes.	
All	four	mononuclear	complexes	Ru•E,	Ru•L,	Ru•E2	and	Ru•L2	were	characterised	by	
UV/Vis	and	luminescence	spectroscopy	(Table	1,	Fig.	1	and	S21).	The	monosubstituted	
complexes	Ru•E	and	Ru•L	both	show,	in	addition	to	the	usual	ligand-centred	absorptions	in	
the	UV	region,	1MLCT	absorptions	spanning	the	375	–	550	nm	region	with	a	maximum	at	
around	440	nm	in	each	case.	These	are	assigned	as	Ru®bipy	and	Ru®phen	1MLCT	
transitions	by	comparison	with	published	spectra:18	we	might	expect	the	Ru®phen	
transition	to	be	at	lower	energy	given	the	alkyne	substituent	conjugated	with	the	phen	core	
which	will	reduce	the	energy	of	the	LUMO,	but	any	such	effect	is	not	clearly	resolved	in	
these	spectra.	However,	for	Ru•E2	and	Ru•L2	the	absorption	spectra	do	clearly	show	this	
effect	(Fig.	S9):	the	second	alkyne	substituent	on	the	phen	ligand	results	in	a	Ru®phen	
1MLCT	transition	that	is	clearly	apparent	as	a	low-energy	shoulder	at	ca.	480	nm	with	the	
more	intense	1MLCT	Ru®bipy	transition	(as	there	are	two	bipy	ligands)	remaining	at	ca.	440	
nm.	
The	luminescence	spectra	in	fluid	and	frozen	solution,	at	RT	and	77	K	respectively	
(Fig.	1),	likewise	reflect	the	general	behaviour	of	[Ru(bipy)3]2+-type	cores18	where	
modification	by	the	alkyne	substituents	slightly	reduces	the	3MLCT	excited	state	energies.19	
For	Ru•E	and	Ru•L	the	broad,	featureless	3MLCT	emission	band	occurs	at	ca.	650	nm,	
slightly	lower	in	energy	than	what	has	been	observed	for	[Ru(bipy)2(phen)]2+	bearing	no	
alkyne	substituents.8a	At	77	K	(frozen	EtOH/MeOH	glass)	the	usual	rigidochromism	results	in	
a	blue-shift	of	the	main	emission	maximum	to	611	nm	(hence,	the	3MLCT	energy	is	16,400	
cm-1,	measured	from	the	0-0	transition	energy)	and	results	in	the	appearance	of	clear	fine-
structure	with	two	low-energy	shoulders	on	the	emission	profile	arising	from	vibronic	
effects.	The	presence	of	the	additional	alkyne	substituent	in	Ru•E2	and	Ru•L2	results	in	an	
additional	red-shift	of	both	the	solution	luminescence	maximum	to	ca.	690	nm.		The	77	K	
emission	spectrum	(frozen	EtOH/MeOH	glass)	of	Ru•E2	is	likewise	red-shifted	to	645	nm	
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compared	to	Ru•E	and	Ru•L.		Ru•L2	was	not	sufficiently	soluble	in	EtOH/MeOH	to	permit	a	
77	K	spectrum	but	it	is	clear	from	comparison	of	Ru•E	and	Ru•L	that	the	presence	or	
absence	of	the	ester	groups	has	no	significant	effect	on	the	luminescence	energy.	This	gives	
a	3MLCT	excited-state	energy	of	15,500	cm-1	for	both	Ru•E2	and	Ru•L2.	Luminescence	
lifetimes	in	air-equilibrated	solution	at	RT	for	all	four	complexes	are	in	the	region	of	100	–	
300	ns;	these	become	longer	(µs	timescale)	at	77	K	(see	Table	1).	
	
Heteronuclear	Ru•M	and	Ru•M2	complexes	(M	=	Gd,	Nd,	Yb).			
	 UV/Vis	absorption	spectra	in	water	(Table	2)	revealed	that	coordination	of	the	Gd(III)	
centre	had	little	effect	on	the	main	spectral	features	which	are	of	course	associated	with	the	
Ru(II)	tris-diimine	core.18	Thus	the	absorption	spectrum	of	Ru•Gd	is	similar	to	that	of	Ru•L.	
However,	we	can	see	that	for	Ru•Gd2	the	lowest	energy	1MLCT	absorption	feature	–	a	
shoulder	associated	with	the	Ru®phen	transition	–	is	slightly	red-shifted	by	about	10	nm	
compared	to	Ru•L2.	This	can	be	ascribed	to	the	electronic	effect	of	a	3+	cation	coordinated	
to	each	of	the	two	pyridine	groups	pendant	from	the	phen	ligand,	which	will	reduce	the	
LUMO	in	energy	and	cause	red-shifting	of	the	associated	Ru®phen	absorption.	Excitation	
into	the	1MLCT	absorption	profile	afforded	the	characteristic	broad,	featureless	(in	fluid	
solution)	3MLCT	luminescence	band	in	each	case,	at	664	nm	and	700	nm	for	Ru•Gd	and	
Ru•Gd2,	respectively	(Fig.	2).	These	are	slightly	red-shifted	from	the	emission	maxima	for	
Ru•L	and	Ru•L2,	since	coordination	of	the	pyridyl	groups	pendant	from	the	phen	ligand	to	
the	3+	ions	reduces	the	LUMO	energy	slightly,	which	is	also	why	a	red-shift	was	observed	in	
the	absorption	spectra.		Photophysical	data	for	these	complexes,	including	luminescence	
lifetimes	and	quantum	yields,	are	included	in	Table	2.	
	 The	UV/Vis	absorption	spectra	for	the	Ru/Yb	and	Ru/Nd	complexes	in	water	are	
identical	within	experimental	error	to	those	of	the	analogous	Ru/Gd	complexes	described	
earlier,	as	the	electronic	effects	of	the	peripheral	Gd(III),	Nd(III)	and	Yb(III)	ions	on	the	
absorption	features	of	the	Ru(II)	tris-diimine	core	are	essentially	identical	and	thus	require	
no	further	discussion.	However,	the	effects	of	the	different	lanthanide	ions	on	the	
luminescence	are	substantial	and	are	most	easily	discussed	in	terms	of	comparison	with	the	
Ru/Gd	complexes,	as	in	these	complexes	Gd(III)	is	non-luminescent:	the	lowest	excited	state	
for	the	Gd(III)	ion	(6P7/2	≈	32,000	cm-1)	is	far	too	high	in	energy	to	be	directly	populated	by	
Ru®Gd	PEnT.	
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Fig.	2	shows	the	emission	spectra	in	the	visible	region	of	all	six	Ru•Ln	and	Ru•Ln2	
complexes	(Ln	=	Gd,	Nd,	Yb)	in	water,	recorded	on	samples	prepared	to	have	the	same	
optical	density	at	the	excitation	wavelength	of	430	nm,	such	that	comparisons	of	emission	
intensities	are	a	meaningful	indication	of	quantum	yield	variations.	It	is	immediately	clear	
that	(i)	the	emission	maxima	for	all	three	Ru•Ln2	complexes	is	at	longer	wavelength	(700	
nm)	than	the	emission	maxima	for	all	three	Ru•Ln	complexes	(662	–	664	nm),	for	reasons	
discussed	earlier,	and	(ii)	the	intensity	of	Ru(II)-based	emission	within	each	set	of	three	
complexes	decreases	in	the	order	Gd	>	Yb	>	Nd.	Thus,	compared	to	Ru•Gd,	the	quenching	
arising	from	the	presence	of	Yb(III)	and	then	Nd(III)	is	10	%	and	45	%,	respectively:	and	
compared	to	Ru•Gd2,	the	quenching	arising	from	the	presence	of	Yb(III)	and	then	Nd(III)	is	
45	%	and	90	%,	respectively	(Table	3).		
This	quenching	of	Ru(II)-based	emission	by	Yb(III)	and	Nd(III)	is	a	consequence	of	
PEnT	from	the	Ru(II)-based	3MLCT	state	to	lower-lying	f-f	excited	states	of	the	relevant	
Ln(III)	ions.		The	different	degrees	of	quenching,	arising	from	different	extents	of	Ru®Ln	
PEnT,	can	be	readily	understood	in	terms	of	the	spectroscopic	overlap	between	donor	and	
acceptor	states.1a,20		Yb(III)	has	a	single	f-f	excited	state	at	ca.	10,200	cm-1	(absorption	at	980	
nm)	which	overlaps	only	with	the	low-energy	tail	of	the	Ru(II)-based	emission	profile	that	
has	vanishingly	small	intensity	at	980	nm.		In	contrast	Nd(III)	has	a	large	number	of	closely-
spaced	f-f	excited	states	between	10,000	cm-1	and	15,000	cm-1,	in	the	region	covered	by	the	
Ru(II)-based	emission	spectrum,	so	donor/acceptor	overlap	will	be	much	better.		Indeed,	it	
is	generally	true	that	for	excited	states	of	donors	in	the	visible	region	of	the	spectrum,	
Nd(III)	is	a	far	better	energy	acceptor	than	Yb(III)	for	this	reason,1a,20	and	we	see	this	in	both	
series	of	complexes	Ru•Ln	and	Ru•Ln2.	
Time-resolved	measurements	on	the	Ru(II)-based	luminescence	allows	the	Ru®Ln	
PEnT	rates	to	be	quantified.	For	Ru•Gd	the	Ru(II)-based	luminescence	in	air-equilibrated	
water	at	RT	is	350	ns;	in	Ru•Yb	and	Ru•Nd	the	luminescence	decay	is	dominated	by	shorter-
lived	components	with	t	=	73	ns	and	22	ns	respectively	(Table	3),	confirming	the	greater	
ability	of	the	Nd(III)	ion	to	act	as	a	quencher	of	the	Ru(II)-based	excited	state.		A	very	small	
contribution	to	the	luminescence	decay	from	a	long-lived	decay	component	with	t	≈	300	ns	
(<	5	%)	is	ascribed	to	a	trace	of	free	Ru•L.			
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kPEnT	=	1/tq	–	1/tu	 	 	 	 	 (2)	
	
Using	equation	2	[where	tu	is	the	‘unquenched’	lifetime	of	Ru•Gd,	and	tq	is	the	partially	
quenched	lifetime	of	the	Ru•Ln	complexes	(Ln	=	Yb,	Nd)]	the	Ru®Yb	and	Ru®Nd	energy-
transfer	rates	of	1.1	x	107	s-1	and	4.2	x	107	s-1,	respectively,	were	estimated.		These	values	
are	broadly	comparable	to	what	we	observed	in	the	Ir/Ln	complexes	based	on	the	same	
ligand	skeleton,6a	and	these	relatively	high	PEnT	rates	are	a	consequence	of	the	fully	
conjugated	pathway	connecting	the	two	metal	complex	components	within	each	molecule.			
The	decay	of	the	Ru(II)-based	emission	in	Ru•Gd2	showed	two	components:	a	longer	
lifetime	of	t1	=	402	ns	(20%	of	total)	and	a	dominant	shorter	component	of	t2	=	164	ns	(80	%	
of	total	emission	intensity).		We	tentatively	ascribed	the	presence	of	a	second	longer-lived	
component	to	the	presence	of	different	conformers	of	the	complex	arising	from	the	
presence	of	multiple	diastereoisomers	(see	sections	on	the	1H	NMR	spectra	of	the	
analogous	Ru/Zn	complexes,	and	conformational	flexibility	of	dinuclear	complexes	studied	
computationally).	In	Ru•Yb2	and	Ru•Nd2	the	luminescence	decay	profiles	are	dominated	by	
short-lived	components	with	t	=	88	ns	and	18	ns	for	Ru•Yb2	and	Ru•Nd2	respectively,	with	
(again)	a	small	amount	of	a	long-lived	component	likely	corresponding	to	traces	of	free	
Ru•L2.		Application	of	eq.	2	(taking	tu	=	164	ns,	the	dominant	component	of	emission	from	
Ru•Gd2)	yields	energy-transfer	rates	of	5.3	x	106	s-1	(for	Ru®Yb	PEnT)	and	4.9	x	107	s-1	(for	
Ru®Nd	PEnT),	again	confirming	that	Nd(III)	is	a	better	energy-acceptor	than	Yb(III)	in	these	
complexes	due	to	its	higher	density	of	excited	states	in	the	relevant	spectral	region.1a,20	
Final	proof	that	Ru®Ln	PEnT	has	occurred	in	the	Yb(III)	and	Nd(III)	complexes	is	shown	by	
the	appearance	of	sensitised	Ln(III)-based	luminescence	following	excitation	into	the	Ru(II)-
based	1MLCT	absorption	band	of	the	complexes	in	D2O	(the	deuterated	solvent	is	used	to	
minimise	solvent-based	quenching	of	the	low	energy	lanthanide	luminescence).21		Fig.	3	
shows	the	spectra	of	Ru•Yb2	and	Ru•Nd2;	those	of	Ru•Yb	and	Ru•Nd	are	similar.	Both	
Yb(III)-containing	complexes	display	a	characteristic	Yb(III)-based	emission	feature	centred	
at	980	nm	arising	from	the	2F5/2®2F7/2	transition.	Time-resolved	measurements	afforded	
Yb(III)-based	luminescence	lifetimes	of	13	µs	for	Ru•Yb	and	11	µs	for	Ru•Yb2	(Table	3).	
Lifetimes	in	this	region	are	typical	of	Yb(III)-based	luminescence	in	fluid	solution	where	the	
effect	of	the	solvent	is	minimised	by	encapsulation	of	the	metal	ion	in	a	polydentate	ligand,	
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and/or	by	deuteriation	of	the	solvent	(as	here).22		The	two	Nd(III)-containing	complexes	
show	luminescence	bands	at	1060	nm	and	1380	nm,	arising	from	the	4F3/2®4IJ	transitions	(J	
=	11/2	and	13/2),	respectively.	Time-resolved	measurements	on	the	1060	nm	signal	
afforded	Nd(III)-based	emission	lifetimes	of	0.8	µs	for	Ru•Nd	and	0.7	µs	for	Ru•Nd2.	Again,	
these	are	typical	values	for	Nd(III)-based	emission	in	fluid	solution	when	there	are	no	OH	
oscillators	in	the	solvent,22	with	the	much	shorter	luminescence	from	Nd(III)	centres	
compared	to	Yb(III)	arising	from	the	lower	energy	associated	with	luminescence	which	is	
more	readily	quenched	by	molecular	(or	solvent)	vibrations.	Finally,	excitation	spectra	–	
monitoring	the	Ln(III)-based	emission	intensity	as	a	function	of	excitation	wavelength	–	
revealed	areas	of	absorbance	between	400	and	500	nm	associated	with	the	Ru(II)-based	
1MLCT	transitions,	confirming	the	occurrence	of	Ru®Ln	PEnT	in	all	cases	(see	SI,	Fig.	S22	for	
examples).	
	
Heteronuclear	Ru•M	and	Ru•M2	complexes	(M	=	Mn,	Zn).		
UV/Vis	absorption	spectra	for	the	set	of	four	Ru/Mn	and	Ru/Zn	complexes	(Table	2)	
follow	the	same	pattern	that	we	saw	with	the	Ru/Ln	complexes,	i.e.	the	absorption	spectra	
are	essentially	the	same	as	the	complexes	Ru•Gd	and	Ru•Gd2	with	no	significant	
contributions	from	the	Mn(II)	or	Zn(II)	ions,	as	would	be	expected	given	their	high-spin	d5	
and	d10	electronic	configurations.	To	confirm	that	the	low	luminescence	intensity	from	the	
Ru/Mn	complexes	is	specifically	associated	with	the	presence	of	the	Mn(II)	ions,	we	
compared	the	luminescence	properties	of	the	Ru/Mn	complexes	to	the	Ru/Zn	analogues	
Ru•Zn	and	Ru•Zn2	(see	Fig.	5).	The	substantial	additional	quenching	caused	by	Mn(II)	ions	
over	Zn(II)	ions	–	as	shown	by	reduction	in	emission	intensity	by	approximately	80	%	–	
confirms	the	role	of	Mn(II)	in	the	quenching.			
This	quenching	could	have	two	possible	origins:	(i)	photoinduced	electron-transfer	
(PET)	from	Mn(II)	to	the	Ru(III)	centre	that	is	photo-generated	in	the	[Ru3+–phen•–]	3MLCT	
state;23	or	(ii)	photoinduced	energy-transfer	from	the	3MLCT	state	to	Mn(II),	generating	a	d-
d	excited	state	of	Mn(II)	that	cannot	be	populated	by	direct	absorption	from	the	ground	
state	as	it	is	spin-forbidden,	but	could	be	generated	by	energy-transfer	from	the	Ru-based	
3MLCT	state	acting	as	a	sensitiser.24		Assemblies	based	on	Ru(II)	chromophores	connected	to	
mononuclear	or	polynuclear	Mn(II)	units	have	been	extensively	studied	because	of	their	
relevance	to	the	PET	properties	of	photosystem	II	in	green	plants.		Indeed,	Hammarström,	
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Åkermark	and	co-workers	have	demonstrated	that	Mn(II)®Ru(III)	PET	occurs	in	a	series	of	
Ru(III)/Mn(II)	dyads	in	which	the	Ru(III)	centre	has	been	generated	by	photo-oxidation	of	a	
Ru(II)	unit,	provided	the	metal	centres	are	close	together.23a-c		
Time-resolved	luminescence	measurements	on	Ru•Zn	and	Ru•Zn2	(in	air-
equilibrated	aqueous	solution)	revealed	3MLCT	emission	lifetimes	that	are	similar	to	those	
of	Ru•Gd	and	Ru•Gd2.	For	Ru•Zn	a	single-exponential	luminescence	decay	of	329	ns	was	
observed;	for	Ru•Zn2	the	decay	profile	fitted	to	two	components	with	t1	=	301	ns	(55%)	and	
t2	=	117	ns	(45%),	very	similar	to	what	we	also	observed	for	Ru•Gd2.	We	therefore	propose	
–	for	the	same	reason	as	suggested	earlier	–	that	the	two	lifetimes	arise	from	a	mixture	of	
diastereoisomers	with	different	conformations.	We	note	that	in	this	case	individual	lifetimes	
may	not	have	specific	physical	meaning,	as	it	is	a	distribution	of	lifetimes	(multiexponential	
decay)	which	has	been	fitted	satisfactorily	with	a	two-exponential	model.		In	contrast	the	
partial	quenching	in	Ru•Mn	and	Ru•Mn2	leads	to	a	shorter	component	dominating	the	
3MLCT	emission	decay	profiles,	with	lifetimes	of	91	ns	for	Ru•Mn	and	21	ns	for	Ru•Mn2.	In	
both	cases	small	contributions	from	a	longer-lived	component	were	also	present,	consistent	
with	traces	of	free	Ru•L	and	Ru•L2	being	present	due	to	loss	of	Mn(II)	ions	from	the	binding	
sites	of	Ru•Mn	and	Ru•Mn2	in	the	competitive	solvent.		However,	the	dominant	short-lived	
components	indicate	quenching	of	the	Ru(II)	excited	state	by	the	Mn(II)	ions:	these	emission	
lifetimes	did	not	change	significantly	over	a	range	of	concentrations	from	4	µM	to	90	µM,	
i.e.	the	quenching	processes	in	Ru•Mn	and	Ru•Mn2	are	intramolecular.			
The	decreased	luminescence	lifetimes	(tens	of	ns)	are	not	the	whole	story	however,	
since	the	limitation	of	our	luminescence	lifetime	spectrometer	(ca.	1	ns	time	resolution)	
means	that	any	faster	decay	processes	associated	with	e.g.	rapid	PET	are	not	detectable	on	
this	instrument.		To	investigate	whether	any	ultrafast	processes	were	occurring	on	the	
timescale	faster	than	1	ns,	the	excited	state	dynamic	behaviour	of	Ru•Zn	and	Ru•Mn	was	
investigated	using	femtosecond	transient	absorption	spectroscopy	(TA).		Here,	Ru•Zn	acts	
as	a	control	since	any	inter-metal	PET	or	PEnT	processes	that	occur	in	Ru•Mn	cannot	occur	
in	Ru•Zn.	Excitation	(λexc	=	400	nm,	40	fs	pulse,	3	mW)	of	a	solution	of	either	Ru•Zn	or	
Ru•Mn	in	aerated	water,	followed	by	measurement	of	the	absorption	spectra	at	a	series	of	
time	delays	up	to	5	ns,	produced	similarly	shaped	differential	TA	spectra	for	both	complexes	
(Fig.	5a,	6a).	There	are	negative	signals	(bleaches)	of	the	MLCT	transitions	at	442/480	nm,	
and	positive	signals	that	have	maxima	at	367	nm	and	456	nm	present	in	both	spectra,	as	
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well	as	a	broad	absorption	in	the	range	500-700	nm	with	a	maximum	at	620	nm.	These	
transient	spectral	features	approximately	resemble	those	of	the	[phen]•–	radical	anion	in	
other	reduced	metal	complexes	such	as	[ReICl(CO)3(phen•–)]–.25		Thus	the	transient	
absorption	spectra	are	in	agreement	with	the	initial	population	of	an	MLCT	state	in	both	
cases.	
Analysis	of	the	dynamics	of	the	transient	signals	for	each	of	the	heteronuclear	
complexes	reveals	different	decay	kinetics	for	Ru•Zn	and	Ru•Mn.	The	dynamic	behaviour	of	
Ru•Zn	(Fig.	5b)	is	described	by	two	lifetime	components;	a	long-lived	component	(blue	trace	
in	the	figure)	that	does	not	completely	decay	over	the	pump-probe	delay	period,	and	a	
much	shorter-lived	component	(red	trace)	with	a	lifetime	of	6	ps.		Decay-associated	spectra	
for	the	different	lifetime	components	are	in	SI	(Fig.	S23).		The	shorter-lived	component	can	
be	ascribed	to	fast	vibrational	cooling	within	the	complex,	whereas	the	longer-lived	
component	can	be	ascribed	to	the	Ru-based	3MLCT	state,	for	which	an	emission	lifetime	was	
measured	as	329	ns	in	aerated	water	(see	earlier).		An	accurate	lifetime	for	the	3MLCT	state	
could	not	be	determined	by	femtosecond	TA	as	it	is	much	longer	than	the	maximum	
possible	time	delay	of	the	experiment.	
The	dynamic	behaviour	of	the	transient	absorption	spectra	for	Ru•Mn	is	more	
complicated	than	for	Ru•Zn	(Fig.	6b),	and	requires	three	lifetime	components	to	fit	the	
decay	profile	satisfactorily.	A	short-lived	component	with	a	lifetime	of	2	ps	(green	trace)	is	
ascribed	to	fast	vibrational	cooling	within	the	complex.	A	further	decay	process	with	a	
lifetime	of	584	ps	(red	trace)	is	synchronous	with	the	grow-in	for	a	second	state	which	then	
decays	more	slowly,	with	an	estimated	lifetime	of	4.7	ns	(blue	trace).		As	the	processes	on	
these	timescales	are	not	present	in	Ru•Zn,	we	suggest	that	they	are	a	consequence	of	fast	
processes	occurring	between	metal	centres	in	the	excited	state	of	Ru•Mn,	with	one	
component	decaying	at	the	same	rate	as	the	other	grows,	in	a	PET	or	PEnT	process.		Again,	
decay-associated	spectra	for	the	different	lifetime	components	are	in	SI	(Fig.	S23),	and	the	
evolution-associated	spectra	(experimental	TA	at	different	time	delays)	for	both	Ru•Zn	and	
Ru•Mn	are	in	Fig.	S24.			
If	the	584	ps	decay	process	were	PEnT	from	the	Ru(II)-based	3MLCT	state	to	the	
Mn(II)	centre,	we	would	see	decay	of	the	intense	(phen•–)	transient	signal	with	τ	=	584	ps	as	
the	3MLCT	state	converted	to	a	[Mn(II)]*	state.	However,	this	is	clearly	not	the	case.		There	
is	a	small	change	in	shape	of	the	(phen•–)	transient	signal	on	this	timescale,	but	it	only	
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decays	on	the	longer	timescale	of	τ	=	4.7	ns.		This	is	consistent	with	the	584	ps	process	being	
Mn(II)®Ru(III)	PET	in	which	the	bridging	(phen•–)	is	preserved,	i.e.	the	process	can	be	
written	as	MnII–(phen•–)–RuIII	®	MnIII–(phen•–)–RuII,	generating	a	new	and	lower-energy	
MnIII/(phen	•–)	MLCT	state	which	then	decays	with	τ	=	4.7	ns	(and	is	not	visible	by	
luminescence	spectroscopy).		
The	occurrence	of	Mn(II)®Ru(III)	PET	into	the	Ru-based	3MLCT	state	is	in	agreement	
with	previous	reports	of	the	behaviour	of	[Ru(bipy)3]2+/Mn(II)	dyads	following	
photochemical	oxidation	of	Ru(II)	to	Ru(III),23a-c	which	simply	requires	that	the	Mn(II)/Mn(III)	
redox	potential	is	less	positive	than	the	Ru(II)/Ru(III)	redox	potential.		Attempts	to	
determine	the	Mn(II)/Mn(III)	redox	potential	of	Ru•Mn	by	cyclic	voltammetry	in	water	were	
unsuccessful	possibly	because	the	large	excess	of	electrolyte	used	(NaCl)	resulted	in	the	
Mn(II)	ion	being	stripped	out	of	the	complex.		Similar	issues	have	occasionally	prevented	
detection	of	Mn(II)/Mn(III)	couples	in	other	Ru/Mn	complexes	recorded	in	competitive	
media.23c		Ru•Mn	is	not	sufficiently	soluble	in	polar	organic	solvents	such	as	MeCN	or	DMF	
to	allow	electrochemical	measurements	to	be	made.		However	we	note	that	(i)	the	harder	
N/O-donor	anionic	ligand	donor	set	around	the	Mn(II)	ions	in	Ru•Mn	and	Ru•Mn2,	
compared	to	the	all-nitrogen	donor	sets	used	in	the	Hammarström/Åkermark	complexes,	
will	reduce	the	Mn(II)/Mn(III)	redox	potential	which	will	facilitate	the	PET	process;	and	(ii)	
the	computational	studies	(next	section)	confirm	that	the	Mn(II)	centre	oxidises	before	the	
Ru(II)	centre,	as	required.			
Assuming	that	the	lifetime	of	the	PET	process	in	Ru•Mn	is	584	ps,	the	rate	of	ET	can	
be	estimated	as	ket	=	1.7	x	109	s-1.	This	PET	rate	is	much	faster	than	was	previously	observed	
by	Hammarström,	Åkermark	and	co-workers	who	reported	PET	rates	in	the	range	ket	=	2	x	
105	–	2	x	106	s-1;23a-c	indeed	it	is	faster	than	the	radiative	decay	rate	of	the	Ru(II)	
chromophore.		Thus,	the	Mn(II)®Ru(III)	process	occurs	rapidly	in	the	MnII–(phen•–)–RuIII	
excited	state,	and	does	not	require	photo-oxidation	of	this	state	to	generate	a	long-lived	
MnII–(phen)–RuIII	species	before	the	Mn(II)®Ru(III)	ET	can	occur.	This	high	ET	rate	can	be	
ascribed	to	the	presence	of	a	favourable	pathway	through	the	conjugated	bridging	ligand	in	
Ru•Mn,	which	provides	a	“conductive”	bridge	for	the	ET	process	to	occur,	in	contrast	to	the	
saturated	bridging	ligands	described	previously.23a-c	
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Given	that	this	PET	process	detected	by	TA	spectroscopy	is	fast	(sub-nanosecond	
timescale)	the	final	question	arises	as	to	why	it	does	not	always	occur,	as	shown	by	the	
observation	of	significant	residual	luminescence	(see	Fig.	4;	t	=	91	ns	for	Ru•Mn	and	21	ns	
for	Ru•Mn2).	This	can	be	ascribed	to	the	presence	of	a	mixture	of	conformers,	as	implied	by	
some	of	the	NMR	studies	(Ru/Zn	complexes)	and	other	luminescence	measurements	(Ru/Gd	
complexes.	Rotation	of	the	pyridyl	group	and	its	pendant	aminocarboxylate	units	about	the	
C-C	single	bond	at	the	pyridyl	C4	position	could	lead	the	pyridine	ring	to	adopt	a	
conformation	perpendicular	to	the	phen	unit,	which	would	electronically	decouple	the	
Mn(II)	ion	from	the	{Ru(bipy)2(phen)}2+	core.	In	this	arrangement,	through-bond	PET	would	
be	much	slower.	If	we	assume	this	to	be	the	case,	we	arrive	at	Mn(II)®[Ru(III)]*	PET	rate	
constants	kPET	(using	eq.	2)	of	ca.	8	x	106	s-1	in	Ru•Mn	and	4	x	107	s-1	in	Ru•Mn2	for	those	
decoupled	conformers	in	which	PET	is	slow,	which	is	still	fast	compared	to	the	timescale	of	
Mn(II)®Ru(III)	ET	across	saturated	spacers	in	several	dyads.23a-c		To	investigate	this	further,	
computational	studies	were	performed	on	Ru•Mn	using	density	functional	theory.	
	
Computational	studies	on	the	Ru•Mn	dyad.	
All	calculations	were	performed	using	the	procedures	outlined	in	the	experimental	
details	section.	The	structure	of	the	lowest	sextet	state	of	Ru•Mn	is	given	in	Fig.	7(a).		For	a	
Mn(II)	ion	in	this	N/O-donor	weak-field	coordination	environment	we	expect	a	high-spin	
configuration,	which	is	what	the	spin	density	shows	[Fig.	7(b)].		The	Mn(II)	ion	is	seven	
coordinate16	with	an	approximately	pentagonal	bipyramidal	coordination	geometry.16d		The	
three	N-donor	atoms	are	2.5	Å	from	Mn(II),	whereas	the	four	Mn–O	distances	are	shorter	at	
ca.	2.2	Å,	reflecting	the	partial	negative	charges	on	the	carboxylate	O	atoms		The	pyridine	N-
donor	is	approximately	co-planar	with	two	of	the	carboxylate	O-donors:	one	of	the	amine	
donors	is	slightly	below	this	plane	with	the	other	amine	donor	a	similar	distance	above	it.	
However,	to	a	first	approximation,	the	Mn(II)	ion	is	pentagonal	bipyramidal.	
Given	the	possibility	for	conformational	flexibility	which	might	affect	the	electronic	
coupling	between	the	two	metal	complex	units,	as	discussed	above,	we	looked	at	the	
barrier	to	rotation	of	the	Mn(II)	unit	with	respect	to	the	Ru(II)	core,	around	the	C-C	single	
bond	between	the	alkyne	linker	and	the	pendant	pyridyl	ring.		Calculations	on	this	rotation	
show	that	an	arrangement	with	the	pendant	pyridine	unit	perpendicular	to	the	
phenanthroline	unit	is	not	a	local	minimum.	However,	the	energy	of	this	‘perpendicular’	
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arrangement	is	only	4.6	kJ	mol-1	(or	1.8	kT)	above	the	energy	of	the	co-planar	orientation	
[Fig.	7(a)].		This	small	energy	difference	means	that	rotation	around	the	C–C	bond	is	quite	
facile	such	that	a	large	part	of	the	torsional	space	will	be	sampled	in	solution	at	RT.		This	
includes	torsional	conformations	in	which	the	pyridyl	[coordinated	to	Mn(II)]	and	phen	
[coordinated	to	Ru(II)]	units	are	orthogonal	to	each	other	and	substantially	electronically	
decoupled,	in	agreement	with	our	explanation	of	the	two	observed	PET	rates	for	Ru•Mn.		
The	overlay	in	Fig.	8(a)	shows	that	rotation	around	this	bond	has	little	structural	effect	on	
the	Ru(II)	moiety.	
TD-DFT	calculations	on	the	structure	with	a	planar	orientation	of	the	bridging	ligand	
[Fig.	7(a)]	show	that	there	are	only	a	small	number	of	strong	electronic	transitions	(Fig.	9).	
Inspection	of	the	major	components	of	these	transitions	(see	computational	SI	document)	
shows	that	all	strong	transitions	at	wavelengths	longer	than	450	nm	are	essentially	
Ru®phen	MLCT	states,	in	agreement	with	a	wealth	of	precedent,18	generating	a	local	
Ru(III)/phen•–	moiety	in	a	triplet	excited	state.		Depending	on	the	interaction	between	this	
complex	unit	in	its	3MLCT	excited	state,	and	the	sextet	state	of	the	Mn(II)	ion,	overall	either	
a	quartet	or	an	octet	state	can	arise	following	photo-excitation	of	the	Ru(II)	centre.	Our	
calculations	show	that	the	quartet	state	is	the	lower	of	the	two	possibilities,	indicating	weak	
antiferromagnetic	coupling	between	the	Ru(III)/phen•–	(triplet)	and	Mn(II)	(sextet)	moieties.		
If	this	quartet	state	is	optimized,	then	the	resulting	electron	distribution	will	reflect	the	
relaxation	by	PET	from	Mn(II)	to	the	short-lived	Ru(III)	centre,	and	the	structure	depicted	in	
Fig.	7(c)	is	obtained.		The	associated	spin	density	shows	that	the	molecule	in	this	state	has	
no	spin	density	on	Ru,	i.e.	the	Ru	centre	is	now	Ru(II),	and	there	is	b-spin	density	on	the	
phen	ligand,	indicating	a	phen•–	species.		As	a	result,	the	formal	charge	on	Mn	should	be	3+:	
this	is	also	evident	from	our	inspection	of	the	coordination	geometry	around	this	ion	which	
reveals	substantial	shortening	of	all	of	the	Mn-ligand	bond	distances	[cf.	the	overlay	of	the	
ground-state	sextet	geometry	of	Ru•Mn	and	this	quartet	excited	state,	Fig.	8(b)].		The	
equatorial	metal-ligand	bond	distances	reduce	by	0.1	Å	(all	amine	and	oxygen	donors)	or	by	
0.2	Å	(pyridine	N	donor).		The	axial	bond	distances	reduce	by	0.4	Å.		Thus	a	MnII–(phen•–)–
RuIII	state	is	shown	to	be	the	lowest-energy	state	following	photo-excitation,	confirming	the	
occurrence	of	the	PET	process	that	was	implied	by	the	TA	measurements:	this	is	the	species	
that	has	a	lifetime	of	4.7	ns	according	to	transient	absorption	data.			
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Rotation	of	the	pyridyl	unit	around	the	C–C	bond	separating	it	from	the	alkyne	linker	
to	give	the	‘perpendicular’	orientation	mentioned	earlier	increases	the	energy	of	the	quartet	
excited	state	by	25.1	kJ	mol-1	(or	10.1	kT)	compared	to	the	co-planar	arrangement	–	a	
considerably	larger	difference	that	was	found	for	the	ground	state.	This	suggests	that	in	the	
quartet	MnII–(phen•–)–RuIII	excited	state	there	is	less	torsional	motion	of	the	pyridyl	unit	
with	respect	to	the	phenanthroline	unit,	such	that	the	perpendicular	arrangement	in	the	
quartet	state	can	only	be	accessed	from	the	same	arrangement	in	the	sextet	state.		
Further	confirmation	of	the	occurrence	of	the	intramolecular	PET	process	is	provided	
by	examination	of	the	localisation	of	redox	processes	in	ground-state	Ru•Mn.		Fig.	8(c)	and	
8(d)	show	the	overlay	of	Ru•Mn	with	Ru•Mn+	and	Ru•Mn–,	respectively.	Both	oxidised	and	
reduced	species	were	geometry-optimized	in	the	quintet	state.	The	overlay	between	
Ru•Mn	and	Ru•Mn+	shows	a	similar	structural	change	to	that	seen	in	the	overlay	between	
the	sextet	and	quartet	states	of	Ru•Mn,	as	shown	in	Fig.	8(b).	This	indicates	that	one-
electron	oxidation	does	indeed	happen	at	the	Mn	centre,	yielding	a	formal	charge	of	3+,	and	
that	this	is	therefore	the	site	of	the	first	oxidation.	This	localisation	for	the	first	oxidation	
process	is	also	evident	if	one	considers	the	difference	in	the	total	electron	density	between	
Ru•Mn+	(at	the	geometry	of	Ru•Mn)	and	Ru•Mn	as	depicted	in	7(e):	there	is	a	decrease	in	
electron	density	on	the	Mn	moiety	consistent	with	formation	of	Mn(III),	but	the	electron	
density	of	the	Ru(II)	centre	does	not	change	upon	one-electron	oxidation	of	the	complex.					
In	contrast,	upon	reduction	of	Ru•Mn	to	Ru•Mn–	there	is	almost	no	structural	
change,	as	is	clear	from	the	overlay	in	Fig.	8(d).	The	difference	electron	density	shown	in	Fig.	
7(f)	(between	Ru•Mn–	and	Ru•Mn	at	the	Ru•Mn–	geometry)	confirms	that	the	one-electron	
reduction	is	associated	with	the	phen	ligand.		These	observations	from	computational	
studies	support	our	experimental	findings.	
	
(iii)	Applications	for	imaging:	relaxivity	properties	and	luminescence	imaging	studies	
	
Ru/Gd	complexes.	
	 Relaxivity	measurements	for	Ru•Gd	and	Ru•Gd2	were	performed	at	400	MHz	and	
298	K	in	D2O	by	the	inversion-recovery	technique,	alongside	the	commercial	contrast	agent	
Magnevist®	for	comparison	purposes.	Solutions	of	each	complex	were	prepared	at	five	
different	concentrations	(0	–	2.0	mM)	and	the	longitudinal	relaxation	time	(T1)	for	the	
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residual	H2O	peak	in	each	sample	was	measured	using	a	standard	inversion-recovery	pulse	
sequence.		The	concentration-normalised	longitudinal	relaxivity	value	(r1)	for	each	complex	
was	then	determined	from	a	linear	plot	of	longitudinal	relaxation	time	against	contrast	
agent	concentration	(SI,	Fig.	S25)	in	accordance	with	eq.	1:	
	
	 1/T1obs	=	1/T10		+	r1[M]	 	 	 	 	 (1)	
	
where	r1	is	the	relaxivity	value,	[M]	is	the	complex	concentration,	T1obs	is	the	observed	T1	
value	in	the	presence	of	complex,	and	T10	is	the	value	of	T1	in	the	absence	of	any	complex.	
Under	the	conditions	used	the	reference	compound	Magnevist®	has	r1	=	4.6	mM-1	s-1,	and	
our	new	compounds	Ru•Gd	and	Ru•Gd2	have	r1	=	6.2	and	13.6	mM-1	s-1,	respectively.	The	
increase	in	relaxivity	between	Magnevist®	and	both	Ru/Gd	complexes	can	be	ascribed	to	a	
combination	of	greater	complex	bulk	(and	hence	slower	tumbling	in	solution)	for	Ru•Gd	and	
Ru•Gd2,	and	possibly	also	the	fact	that	the	Gd(III)	ion	binding	site	in	both	Ru/Gd	complexes	
is	heptadentate,	which	leaves	room	for	potentially	two	water	molecules	(q	=	2),	whereas	
Magnevist®	has	q	=	1.		In	fact	the	q	value	for	a	Eu(III)	complex	with	the	same	
aminocarboxylate	donor	set	was	previously	determined	as	1.6	±	0.5,6a	implying	a	mixture	of	
mono-	and	di-aqua	coordination	in	solution.	These	r1	values	compare	favourably	with	those	
for	other	oligonuclear	complexes.4a	
Given	the	promising	relaxivity	properties	of	Ru•Gd	and	Ru•Gd2	we	were	also	
interested	to	see	if	the	Ru(II)-based	luminescence	could	be	used	as	the	basis	of	cellular	
imaging.	Live	HeLa	cells	were	initially	incubated	with	either	of	these	complexes	at	
concentrations	of	25	μM,	50	μM	and	75	μM	for	six	or	sixteen	hours.		Cells	stained	with	
either	of	the	probes	for	the	longer	incubation	period	(16	h)	at	all	concentrations	were	
visually	unhealthy	when	viewed	under	the	microscope,	and	cells	stained	with	the	lowest	
concentration	of	the	probes	(25	μM)	demonstrated	only	weak	Ru(II)-based	emission	even	at	
the	longer	incubation	times.	These	results	suggested,	therefore,	that	shorter	incubation	
times	and	higher	concentrations	would	provide	the	optimum	imaging	conditions	for	both	
complexes.	Accordingly,	further	cellular	staining	was	conducted	with	live	HeLa	cells	
incubated	with	probe	concentrations	of	50	μM,	75	μM	and	100	μM	for	four	hours,	or	with	
an	increased	probe	concentration	(75	μM,	100	μM	and	150	μM)	over	a	shorter	incubation	
period	(two	hours).	In	this	instance	all	of	the	cells	stained	for	each	incubation	time	and	at	
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each	concentration	for	both	probes	were	visually	healthy	when	viewed	under	the	
microscope,	apart	from	the	cells	incubated	with	a	probe	concentration	of	150	μM,	which	
were	beginning	to	detach	from	the	sterile	coverslip.	
Ru(II)-based	emission	was	observed	from	all	of	the	healthy	cells	when	imaged	with	a	
confocal	microscope	(λexc	=	405	nm,	λem	=	570-620	nm):	however,	the	emission	from	the	cells	
incubated	for	only	2	h	(with	either	complex)	was	weak,	suggesting	lower	cellular	uptake.	The	
optimum	imaging	conditions	for	each	complex	were	found	to	be	an	incubation	time	of	4	h	
using	a	concentration	of	50	μM,	which	allowed	for	reasonable	cellular	uptake	without	high	
levels	of	cytotoxicity	being	observed.		Example	emission	images	of	HeLa	cells	incubated	with	
Ru•Gd	and	Ru•Gd2	(Fig.	10)	show	punctate	cytoplasmic	staining,	suggesting	that	both	of	the	
probes	localise	in	a	specific	organelle	within	the	HeLa	cells,	such	as	the	lysosomes	or	the	
mitochondria.	Co-localisation	studies	with	the	commercial	lysosomal	and	mitochondrial	
stains	LysoTracker®	Red	and	MitoTracker®	Red	were	not	successful	as	some	absorbance	of	
these	stains	at	the	excitation	wavelength	used	(405	nm)	produced	red	luminescence	which	
interfered	with	that	of	the	Ru(II)	complexes.		
The	cytotoxicity	of	Ru•Gd	and	Ru•Gd2	towards	HeLa	cells	under	the	optimum	
imaging	conditions	(50	μM,	4	h)	and	also	at	an	increased	probe	concentration	(200	μM,	4	h)	
was	assessed	by	clonogenic	assay	(SI,	Fig.	S26).	Both	of	the	complexes	exhibited	low	toxicity	
under	the	conditions	used	to	image	the	cells,	with	survival	fractions	of	>	0.85	being	
observed	in	both	cases.	Increasing	the	probe	concentration	four-fold	to	200	μM	had	the	
expected	effect	of	lowering	the	cell	survival	fraction	in	comparison	to	the	lower	
concentration,	but	good	survival	levels	were	still	observed	for	both	probes	(>	0.8).	The	
trinuclear	probe	Ru•Gd2	causes	lower	cell	survival	fractions	at	both	probe	concentrations	
when	compared	to	dinuclear	Ru•Gd.	Overall,	the	ability	of	these	complexes	to	act	as	stains	
in	luminescence	imaging	–	in	addition	to	providing	high	relaxivity	for	water	protons	–	is	
clear.			
	
Ru/Mn	complexes	
	 To	see	how	the	Mn(II)	centres	fared	for	relaxivity	purposes	compared	to	Gd(III),	
relaxivity	experiments	on	Ru•Mn	and	Ru•Mn2	were	carried	out	in	D2O	at	400	MHz	and	298	
K,	alongside	the	commercial	Gd(III)-based	contrast	agent	Magnevist®	for	comparison	
purposes	(SI,	Fig.	S27).		Exactly	the	same	methodology	was	used	as	for	the	Ru/Gd	
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complexes,	affording	relaxivity	values	of	r1	=	3.7	mM-1	s-1	and	4.8	mM-1	s-1	for	Ru•Mn	and	
Ru•Mn2	respectively,	which	compare	favourably	to	a	range	of	mononuclear	Mn(II)	
complexes	in	a	similar	N/O-donor	coordination	environment	based	predominantly	on	amine	
and	carboxylate	ligands.14c		Under	the	same	experimental	conditions,	Magnevist®	has	a	
relaxivity	value	of	r1	=	4.6	mM-1	s-1.	We	recall	that	Ru•Gd	and	Ru•Gd2	have	larger	relaxivity	
values	(r1	=	6.2	mM-1	s-1	and	13.6	mM-1	s-1,	respectively).	The	smaller	relaxivity	values	for	the	
Ru/Mn	complexes	compared	to	the	Ru/Gd	analogues	are	of	course	principally	attributable	
to	the	smaller	magnetic	moment	of	Mn(II)	compared	to	Gd(III),	but	the	smaller	number	of	
water	molecules	coordinated	to	the	metal	centre	in	solution	will	be	significant	too.	In	
Magnevist®	the	Gd(III)	ion	is	9-coordinate	from	an	octadentate	DTPA	ligand	and	one	water	
molecule,	whereas	the	smaller	Mn(II)	ion	in	the	same	ligand	is	coordinatively	saturated	by	
the	ligand	(q	=	0).14d		We	observed	a	hydration	number	of	1.6	±	0.5	for	Eu(III)	ions	in	the	
heptadentate	binding	site	used	in	these	complexes,6a	and	by	analogy	with	the	DTPA	
complexes	this	value	will	be	smaller	when	Mn(II)	is	coordinated	at	the	same	binding	site	due	
to	its	smaller	size	and	preference	for	lower	coordination	numbers.		Although	Ru•Mn2	does	
show	relaxivity	similar	to	that	of	Magnevist®,	its	use	as	a	dual	magnetic	resonance	/	
luminescence	imaging	agent	is	inhibited	by	the	fact	that	the	Ru(II)-based	3MLCT	
luminescence	is	partly	quenched	by	the	Mn(II)	ions;	the	same	is	true	for	Ru•Mn.		
	
Conclusion	
	 The	ligand	skeleton	containing	a	phenanthroline	unit	(for	coordination	to	a	
photosensitising	complex	core)	with	one	or	two	pendant	pyridyl/aminodicarboxylate	units	
connected	via	alkyne	linkages	has	been	used	to	prepare	a	variety	of	d/d	and	d/f	
heterodinuclear	and	heterotrinuclear	complexes.	The	central	photosensitising	unit	is	
{Ru(bipy)2(phen)}2+	in	all	cases.	The	secondary	metal	ions	at	the	pendant	sites	are	either	
from	the	f-block	[Gd(III)	for	its	relaxivity;	Nd(III)	or	Yb(III)	for	their	near-infrared	
luminescence]	or	the	d-block	[Mn(II)	for	its	relaxivity	and	ability	to	effect	PET	to	the	excited	
state	of	the	Ru(II)	unit;	and	Zn(II)	as	a	control	for	comparison	with	the	Mn(II)	complexes].	
	 A	range	of	interesting	behaviours	has	emerged.	The	complexes	Ru•Gd	and	Ru•Gd2	
show	relaxivity	of	water	protons	that	is	high	for	the	number	of	Gd(III)	ions	that	they	contain	
because	of	their	size	and,	therefore,	slow	rotation	in	solution;	in	addition	they	retain	the	
characteristic	phosphorescence	of	the	{Ru(bipy)2(phen)}2+	core	which	can	be	used	for	
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luminescence	imaging	of	cells	such	that	they	have	potential	as	dual	(luminescence	and	MRI	
relaxivity)	imaging	agents.	The	analogous	Ru/Yb	and	Ru/Nd	complexes	display	Ru®Yb	and	
Ru®Nd	(respectively)	photoinduced	energy-transfer,	leading	to	partial	quenching	of	the	
Ru(II)-based	emission	and	sensitised	near-infrared	luminescence	from	the	lanthanide	unit.	
The	energy-transfer	to	Nd(III)	is	much	faster	than	to	Yb(III)	because	of	the	higher	density	of	
f-f	excited	states	in	the	correct	spectral	region	on	Nd(III),	which	can	act	as	energy	acceptors.	
	 In	the	Ru/Mn	complexes	Ru•Mn	and	Ru•Mn2	the	presence	of	the	Mn(II)	ions	
likewise	provide	a	basis	for	relaxivity	of	water	protons,	with	relaxivity	values	competitive	
with	other	Mn(II)-based	complexes.	In	this	case	however	the	phosphorescence	of	the	
{Ru(bipy)2(phen)}2+	core	is	substantially	quenched	by	the	Mn(II)	ions	–	similar	quenching	
does	not	occur	when	Mn(II)	is	replaced	by	Zn(II).	Ultrafast	transient	absorption	experiments	
on	Ru•Mn	(and	Ru•Zn	as	a	control)	reveal	the	presence	of	fast	(<	1	ns)	PET	from	the	Mn(II)	
ion	to	the	Ru(II)-based	3MLCT	state,	i.e.	MnII–(phen•–)–RuIII	®	MnIII–(phen•–)–RuII.		The	
resulting	MnIII–(phen•–)	state	decays	with	t	≈	5	ns	and	is	non-luminescent.	This	fast	
quenching	mechanism	does	not	always	occur,	as	shown	by	the	presence	of	residual	Ru(II)-
based	luminescence	in	Ru•Mn	and	Ru•Mn2	(tens	of	ns	lifetime),	which	we	ascribe	to	the	
presence	of	a	conformer	in	which	the	central	and	peripheral	metal	complex	centres	are	
decoupled	by	rotation	of	the	pyridyl	units	such	that	they	are	perpendicular	to	the	phen	unit.	 	
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Experimental	
	
General	details.		
All	reagents,	unless	otherwise	stated,	were	purchased	from	commercial	sources	
(Sigma-Aldrich,	Alfa	Aesar,	Fluorochem)	and	used	as	received.	All	solvents	were	of	HPLC	
grade	quality	and	obtained	from	Fisher,	excluding	deuterated	solvents	(Sigma-Aldrich,	Acros	
Organics,	VWR).	Dry	solvents	were	obtained	from	the	Grubbs	dry	solvent	system	at	the	
University	of	Sheffield.	The	following	materials	were	prepared	using	literature	procedures:	
4-bromo-2,6-bis[N,N-bis(tert-butoxycarbonylmethyl)aminomethyl]pyridine	(compound	B),12	
3-bromo-1,10-phenanthroline,9	3,8-dibromo-1,10-phenanthroline,9	[Ru(bipy)2Cl2]•2H2O.26	
	
Instrumentation.		
One-dimensional	1H	and	13C	NMR	spectra	and	two-dimensional	COSY	spectra	were	
recorded	using	either	a	Bruker	Avance	III	HD	400	spectrometer	or	a	Bruker	Avance	III	HD	
500	spectrometer.	Electrospray	ionisation	(ES)	mass	spectra	were	recorded	on	an	Agilent	
Technologies	6530	Accurate-Mass	Q-TOF	LC/MS	instrument	(University	of	Sheffield).	High-
resolution	spectra	were	recorded	on	a	Bruker	MaXis	plus	instrument	(University	of	
Warwick).	UV/Vis	spectra	were	measured	on	a	Varian	Cary	50	Bio	UV-Visible	
Spectrophotometer.			
Photoluminescence	spectra	were	recorded	on	a	Horiba	Jobin	Yvon	Fluoromax-4-
Spectrofluorimeter	and	were	corrected	using	correction	files	included	within	the	
FluorEssenceTM	software.	Near-IR	emission	and	excitation	spectra	of	the	Yb(III)	and	Nd(III)	
complexes	were	recorded	on	an	Edinburgh	Instrument	FP920	Phosphorescence	Lifetime	
Spectrometer	equipped	with	a	450	watt	steady	state	xenon	lamp;	a	5	watt	microsecond	
pulsed	xenon	flashlamp	(with	single	300	mm	focal	length	excitation	and	emission	
monochromators	in	Czerny	Turner	configuration);	a	red	sensitive	photomultiplier	in	a	Peltier	
(air	cooled)	housing	(Hamamatsu	R928P);	and	a	liquid	nitrogen	cooled	NIR	photomultiplier	
(Hamamatsu),	and	were	corrected	using	correction	files	included	within	the	software.	Near-
IR	emission	spectra	were	recorded	using	a	645	nm	longpass	filter.	Low-temperature	
emission	spectra	in	the	visible	region	were	measured	in	frozen	(77	K)	glasses	of	
ethanol/methanol	(4:1,	v:v).	Decay	curves	generated	by	single	photon	counting	(SPC)	were	
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fitted	using	Origin®	software	and	the	quality	of	fit	judged	by	minimization	of	reduced	chi-
squared	and	sum-of-residuals	squared	values.	
	
NMR	relaxivity	measurements.	
	 Relaxivity	measurements	for	Ru•Gd,	Ru•Gd2,	Ru•Mn,	Ru•Mn2	and	the	commercial	
contrast	agent	gadopentetic	acid	(‘Magnevist®’)	were	performed	on	a	Bruker	Avance	III	400	
spectrometer	at	298	K.	Each	compound	under	investigation	was	dissolved	in	D2O	at	five	
different	concentrations	(0	–	2.0	mM)	and	the	spin-lattice	relaxation	time	(T1)	for	the	
residual	H2O	peak	in	each	sample	measured	using	a	standard	inversion-recovery	pulse	
sequence	with	12	recovery	times	varying	between	0.001-60	seconds	for	gadopentetic	acid	
and	15	recovery	times	varying	between	0.001-15	seconds	for	the	four	new	complexes.	
Relaxivity	values	were	determined	from	a	linear	plot	of	spin-lattice	relaxation	time	(T1)	
against	contrast	agent	concentration	(0	–	2.0	mM)	in	accordance	with	eq.	1.	
Cell	imaging	studies.	
	 HeLa	cells	were	cultured	in	Dulbecco’s	modified	eagle	medium	(DMEM,	high	glucose	
with	L-glutamine)	purchased	from	Lonza	(500	mL)	and	supplemented	with	10	%	(v/v)	foetal	
bovine	serum	(FBS).	Cultures	were	grown	as	monolayers	in	T-75	flasks	at	37	°C	in	a	5	%	CO2	/	
95	%	air	(v/v)	environment.	Once	at	75-80	%	confluency,	cells	were	subcultured	using	
trypsin-	EDTA	(2	mL).	Subcultures	for	live	cell	staining	were	seeded	on	to	sterile	coverslips	
(15	mm	x	15	mm)	in	6-well	plates	(100,000/well)	and	those	for	clonogenic	assays	were	
seeded	directly	in	to	6-well	plates	(200-400/well).	All	subcultures	were	incubated	in	DMEM	
at	37	°C	in	a	5	%	CO2	/	95	%	air	(v/v)	environment	overnight	to	allow	for	adhesion	to	the	
well-plate	or	coverslip.	
For	cell	staining,	Ru•Gd	and	Ru•Gd2	were	dissolved	in	sterile,	double-distilled	water	
to	form	stock	solutions	with	a	concentration	of	1	mM.	Further	dilution	to	generate	working	
solutions	of	50-200	μM	was	achieved	using	DMEM	supplemented	with	10	%	(v/v)	FBS.	After	
removal	of	the	growth	media,	cells	were	washed	with	sterilised	phosphate-buffered	saline	
(PBS,	3	x	2	mL/well)	before	being	treated	with	a	solution	of	the	appropriate	Ru/Gd	complex	
at	concentrations	of	50	–	200	μM	(2	mL/well).	Cells	were	incubated	for	2	h	or	4	h	at	37	°C	in	
DMEM	in	a	5	%	CO2	/	95	%	air	(v/v)	environment.	After	the	desired	incubation	time	the	
growth	medium	was	removed	and	the	cells	were	washed	with	PBS	(3	x	2	mL/well)	to	
remove	excess	metal	complex.	The	cells	were	then	treated	with	paraformaldehyde	solution	
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(4	%	in	PBS,	1	mL/well)	for	20	minutes,	before	being	washed	again	with	PBS	(3	x	2	mL/well).	
The	coverslips	were	mounted	on	to	microscope	slides	(Immu-MountTM,	Thermo	Scientific)	
and	left	to	dry	for	a	minimum	of	30	minutes	before	imaging.	Confocal	images	of	fixed	HeLa	
cells	were	recorded	using	an	inverted	Nikon	A1	confocal	microscope	with	a	60x	lens	(CFI	
Plan	Apochromat	VC	60x	oil,	NA	1.4).	A	diode	laser	(405	nm)	was	used	for	excitation	of	the	
Ru/Gd	complexes	and	a	570-620	nm	emission	filter	was	used.	
	
Toxicity	assay	
After	removal	of	the	growth	media,	live	HeLa	cells	were	treated	with	a	solution	of	
Ru•Gd	or	Ru•Gd2	complex	in	media	at	both	50	μM	and	200	μM	(1	mL/well).	Cells	in	four	
control	wells	were	left	untreated	and	immersed	in	DMEM	(2	mL/well).	Cells	were	incubated	
for	4	h	at	37	°C	in	a	5	%	CO2	/	95	%	air	(v/v)	environment.	Following	incubation,	the	
treatment	solution	was	removed,	and	the	cells	immersed	in	fresh	DMEM	(2	mL/well)	and	
incubated	for	seven	to	ten	days	at	37	°C	in	a	5	%	CO2	/	95	%	air	(v/v)	environment	until	
visible	cell	colonies	had	formed.	The	growth	medium	was	removed,	and	the	cells	were	fixed	
and	stained	with	methylene	blue	in	methanol	(4 g/L)	for	a	minimum	of	30	minutes.	The	
staining	solution	was	removed,	and	the	number	of	colonies	counted,	with	each	colony	
representing	a	surviving	cell.	The	‘survival	fraction’	for	cells	treated	with	the	Ru/Gd	
complexes	is	the	number	of	colonies	formed	after	treatment	with	Ru/Gd	complexes	
compared	to	controls	in	the	absence	of	complex.	Experiments	were	conducted	in	duplicate	
for	seeding	densities	of	200	and	400	cells/well	and	repeated	on	three	separate	occasions.	
Survival	fractions	quoted	are	averages	of	the	three	repeats.	
	
Transient	absorption	spectroscopy	measurements	
	 A	Ti:Sapphire	regenerative	amplifier	(Spitfire	ACE	PA-40,	Spectra-Physics)	provided	
800	nm	pulses	(40	fs	fwhm,	10	kHz,	1.2mJ);	400	nm	for	sample	excitation	was	provided	by	
doubling	a	portion	of	the	800	nm	output,	in	a	β-barium	borate	crystal	within	a	commercially	
available	doubler/tripler	(TimePlate,	Photop	Technologies).	White	light,	supercontinuum,	
probe	pulses	were	generated	in	situ	by	using	a	portion	of	the	Ti:sapphire	amplifier	output,	
focused	onto	a	CaF2	crystal,	allowing	for	the	generation	of	light	spanning	340	–	790	nm.	
Detection	was	achieved	using	a	commercial	transient	absorption	spectrometer	(Helios,	
Ultrafast	Systems)	and	was	performed	by	a	CMOS	sensor	for	the	UV/Vis	spectral	range.	The	
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relative	polarisation	of	the	pump	and	probe	pulses	was	set	to	the	magic	angle	of	54.7˚	for	
anisotropy-free	measurements.		Samples	were	held	in	1	mm	path	length	quartz	cells.	The	
optical	density	at	the	excitation	wavelength	was	kept	at	approximately	0.5.	The	optical	
density	across	the	probe	range	was	kept	below	0.8.	
	 Excited	state	dynamics	were	elucidated	by	global	lifetime	analysis,	performed	in	
Glotaran.27	Difference	spectra	were	baseline	corrected	through	subtraction	of	an	average	of	
the	pre-excitation	spectra.		Sequential	kinetic	models	were	then	applied	to	each	dataset	to	
model	the	excited	state	dynamics.	A	polynomial	curve	was	fit	to	the	data	to	account	for	the	
group	velocity	dispersion	of	the	probe	light	in	the	kinetic	model.	The	number	of	lifetime	
components	was	systematically	varied	in	order	to	minimise	the	residual	intensity	between	
the	experimental	and	model	data,	where	the	minimum	χ2	value	had	been	obtained.	
	
Synthesis	
	 4-(Trimethylsilyl)ethynyl-2,6-bis[N,N-bis(tert-butoxycarbonylmethyl)-
aminomethyl]pyridine	(compound	CSi).	A	mixture	of	4-bromo-2,6-bis[N,N-bis(tert-
butoxycarbonylmethyl)-aminomethyl]pyridine	(compound	B;	6.89	g,	10.2	mmol),	
Pd(PPh3)2Cl2	(0.50	g,	0.712	mmol),	CuI	(0.30	g,	1.58	mmol)	and	PPh3	(0.10	g,	0.381	mmol)	
were	added	to	anhydrous	iPr2NH	(30	cm3)	and	the	mixture	deoxygenated	with	argon	gas	for	
30	minutes.	Trimethylsilyl-acetylene	(15	cm3,	108	mmol)	was	added	with	vigorous	stirring	
and	the	resulting	mixture	heated	at	83	°C	for	24	hours.	Once	cooled,	the	reaction	was	
filtered	through	celite®	and	washed	with	CH2Cl2	until	the	washings	ran	clear.	The	solvent	
was	then	removed	under	reduced	pressure	to	afford	a	black	residue,	which	was	flash-
filtered	through	silica	gel	(200-300	mesh)	with	CH2Cl2	as	eluent.	The	crude	product	was	then	
purified	further	using	column	chromatography	on	silica	gel	(200-300	mesh)	with	petroleum	
ether/	ethyl	acetate	(9:1	to	8:2,	v:v)	as	the	eluent	to	afford	4-(trimethylsilyl)ethynyl-2,6-
bis[N,N-bis(tert-butoxy-carbonylmethyl)aminomethyl]pyridine	(CSi:	4.25	g,	60	%)	as	a	dark	
yellow	oil.	1H	NMR	(400	MHz,	CDCl3):	δ	=	0.18	(s,	9H,	SiMe3);	1.42	(s,	36H,	tBu);	3.43	(s,	8H,	
NCH2–ester);	3.96	(s,	4H,	NCH2–pyridyl);	7.48	(s,	2H,	pyridyl	H3/H5).	ESMS:	m/z	=	690.4	[M	+	
H]+,	712.4	[M	+	Na]+.	
4-Ethynyl-2,6-bis[N,N-bis(tert-butoxycarbonylmethyl)-aminomethyl]pyridine	
(compound	C).	Protected	compound	CSi	(0.75	g,	1.09	mmol)	and	tetra-n-butylammonium	
fluoride	(0.43	g,	1.63	mmol)	were	dissolved	in	THF	(45	mL)	and	stirred	at	RT	for	16	hours.	
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The	solvent	was	then	removed	under	reduced	pressure	and	the	resulting	residue	dissolved	
in	CH2Cl2	(30	cm3),	washed	with	water	(2	x	30	cm3)	and	dried	(MgSO4).	The	solvent	was	
removed	under	reduced	pressure	to	afford	compound	C	(0.62	g,	92	%)	as	a	dark	yellow	oil.	
Due	to	the	reactivity	of	the	alkyne	substituent	this	compound	was	used	immediately	after	
preparation	without	further	characterisation.	
[Ru(bipy)2(Br-phen)](PF6)2	(compound	A).	A	mixture	of	3-bromo-1,10-
phenanthroline	(0.95	g,	3.68	mmol)	and	cis-[Ru(bipy)2Cl2]•2H2O	(1.90	g,	3.65	mmol)	in	
CH3OH	(30	cm3)	was	heated	to	reflux	for	16	hours.	Once	cooled,	the	solution	was	
concentrated	under	reduced	pressure	and	an	excess	of	saturated	KPF6(aq)	solution	(20	cm3)	
was	added.	The	solution	was	left	at	4	°C	for	16	hours	and	the	resulting	precipitate	dissolved	
in	CH2Cl2	(30	cm3)	and	washed	with	water	(3	x	25	cm3).	The	combined	aqueous	layers	were	
then	re-extracted	with	further	portions	of	CH2Cl2	(2	x	25	cm3)	and	the	resulting	organic	
extracts	combined	and	dried	(MgSO4).	The	solvent	was	removed	under	reduced	pressure	to	
afford	compound	A	(3.51	g)	as	a	red	solid	in	quantitative	yield.	1H	NMR	(400	MHz,	d6-
acetone):	δ	=	7.36-7.42	(m,	2H,	bipy);	7.60-7.66	(m,	2H,	bipy);	7.85	(dd,	1H,	J	=	1.5	and	5.6	
Hz,	bipy);	7.94	(dd,	1H,	J	=	5.2	and	8.2	Hz,	phen);	8.04	(dd,	1H,	J	=	1.5	and	5.6	Hz,	bipy);	8.10	
(dd,	1H,	J	=	1.5	and	Hz,	bipy);	8.12-8.18	(m,	2H,	bipy);	8.19	(dd,	1H,	J	=	1.5	and	5.6	Hz,	bipy);	
8.25	(tt,	2H,	J	=	1.5	and	7.9	Hz,	bipy);	8.35	(d,	1H,	J	=	8.9	Hz,	phen);	8.44	(dd,	1H,	J	=	1.2	and	
5.2	Hz,	phen);	8.45	(d,	1H,	J	=	8.9	Hz,	phen);	8.47	(d,	1H,	J	=	1.9	Hz,	phen);	8.78	–	8.87	(m,	
5H,	4	x	bipy,	1	x	phen);	9.06	(d,	1H,	J	=	1.9	Hz,	phen).		ESMS:	m/z	=	337	[M	–	2PF6]2+.	High	
resolution	ESMS:	m/z	=	337.0101	(calculated	for	[C32H23N6BrRu]2+,	337.0099).	
[Ru(bipy)2(Br2-phen)](PF6)2	(compound	D).	This	was	prepared	from	3,8-dibromo-
1,10-phenanthroline	(0.33	g,	0.98	mmol)	and	cis-[Ru(bipy)2Cl2]•2H2O	(0.51	g,	0.98	mmol)	
exactly	as	described	above	for	complex	A,	to	afford	compound	D	(1.02	g)	as	a	red	solid	in	
quantitative	yield.	1H	NMR	(400	MHz,	d6-acetone):	δ	=	7.40	(ddd,	2H,	J	=	1.2,	5.6	and	7.9	Hz,	
bipy);	7.63	(ddd,	2H,	J	=	1.2,	5.6	and	7.9	Hz,	bipy);	8.01	(dd,	2H,	J	=	1.5	and	5.6	Hz,	bipy);	8.12	
(dd,	2H,	J	=	1.5	and	5.6	Hz,	bipy);	8.16	(td,	2H,	J	=	1.5	and	7.9	Hz,	bipy);	8.25	(td,	2H,	J	=	1.5	
and	7.9	Hz,	bipy);	8.40	(s,	2H,	phen);	8.48	(d,	2H,	J	=	1.9	Hz,	phen);	8.79	(d,	2H,	J	=	7.9	Hz,	
bipy);	8.83	(d,	2H,	J	=	7.9	Hz,	bipy);	9.07	(d,	2H,	J	=	1.9	Hz,	phen).		ESMS:	m/z	=	376.0	[M	–	
2PF6]2+.	High	resolution	ESMS:	m/z	=	375.9650	(calculated	for	[C32H22N6Br2Ru]2+,	375.9648).	
Compound	Ru•E.	A	mixture	of	compound	A	(0.53	g,	0.55	mmol),	(dppf)PdCl2.CH2Cl2	
(0.05	g,	0.06	mmol)	and	CuI	(0.01	g,	0.05	mmol)	in	anhydrous	DMF	/	iPr2NH	(6	cm3,	5:1,	v:v)	
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was	deoxygenated	with	argon	for	30	minutes.	To	this	was	added	dropwise	a	solution	of	
compound	C	(0.62	g,	1.00	mmol)	in	deoxygenated	anhydrous	DMF	/	iPr2NH	(3	cm3,	5:1,	v:v).	
The	solution	was	stirred	at	room	temperature	for	16	hours	under	argon,	before	removal	of	
the	solvent	under	reduced	pressure.	The	resulting	brown	solid	was	purified	by	column	
chromatography	on	silica	gel	(200-300	mesh)	with	CH3CN/H2O/sat.	KNO3(aq)	(100:0:0	to	
100:4:2,	v:v:v)	as	the	eluent.	The	solvent	was	then	removed	under	reduced	pressure	and	the	
solid	dissolved	in	CH2Cl2	(30	cm3),	washed	with	an	excess	of	saturated	KPF6(aq)	solution	(20	
cm3)	and	separated.	The	aqueous	layer	was	extracted	with	further	portions	of	CH2Cl2	(2	x	15	
cm3)	and	the	combined	organic	layers	then	washed	with	water	(2	x	15	cm3)	and	dried	
(MgSO4).	The	solvent	was	removed	under	reduced	pressure	to	afford	complex	Ru•E	(0.41	g,	
50	%)	as	a	dark	red	solid.	1H	NMR	(400	MHz,	d6-acetone):	δ	=	1.45	(s,	36H,	tBu);	3.49	(s,	8H,	
N–CH2–ester);	4.00	(s,	4H,	CH2–pyridyl);	7.37-7.45	(m,	2H,	bipy);	7.61	(s,	2H,	pyridyl	H3/H5);	
7.62-7.67	(m,	2H,	bipy);	7.88	(d,	1H,	J	=	5.6	Hz,	bipy);	7.96	(dd,	1H,	J	=	5.2	and	8.2	Hz,	phen);	
8.09	(d,	1H,	J	=	5.6	Hz,	bipy);	8.13	(d,	1H,	J	=	5.6	Hz,	bipy);	8.14-8.20	(m,	2H,	bipy);	8.21	(d,	
1H,	J	=	5.6	Hz,	bipy);	8.26	(t,	2H,	J	=	7.9	Hz,	bipy);	8.40-8.50	(m,	3H,	phen);	8.67	(d,	1H,	J	=	1.9	
Hz,	phen);	8.79-8.88	(m,	5H,	4	x	bipy,1	x	phen);	9.04	(d,	1H,	J	=	1.9	Hz,	phen).	ESMS:	m/z	=	
604.7	[M	–	2PF6]2+.	High	resolution	ESMS:	m/z	=	604.7318	(calculated	for	[C65H73N9O8Ru]2+,	
604.7316).	
Compound	Ru•L.	A	solution	of	Ru•E	(73	mg,	0.049	mmol)	in	CH2Cl2	(3	cm3)	and	
trifluoroacetic	acid	(TFA,	3	cm3)	was	stirred	at	room	temperature	for	18	hours.	The	solvent	
was	then	removed	under	reduced	pressure	to	yield	a	red	solid.	To	remove	any	residual	TFA	
the	solid	was	dissolved	in	CH2Cl2	(10	cm3)	and	then	evaporated	to	dryness	in	vacuo.	This	
process	was	repeated	ten	times.	The	solid	was	then	washed	with	CH3OH	(10	x	10	cm3)	
following	the	same	procedure.	Finally,	the	red	solid	was	dissolved	in	the	minimum	amount	
of	CH3OH	and	precipitated	with	an	excess	of	diethyl	ether.	The	solid	was	collected	by	
centrifugation	and	dried	under	a	stream	of	N2	to	yield	Ru•L	(61	mg,	98	%)	as	a	red	solid.	1H	
NMR	(500	MHz,	d6-DMSO,	303	K):	δ	=	3.46	(s,	8H,	N–CH2–acid);	3.94	(s,	4H,	CH2–pyridyl);	
7.33-7.38	(m,	2H,	bipy);	7.53	(d,	1H,	J	=	5.3	Hz,	bipy);	7.56	(s,	2H,	pyridyl	H3/H5);	7.56-7.62	
(m,	2H,	bipy);	7.75	(d,	2H,	J	=	5.3	Hz,	bipy);	7.87	(d,	1H,	J	=	5.3	Hz,	bipy);	7.90	(dd,	1H,	J	=	5.2	
and	8.2	Hz,	phen);	8.07-8.16	(m,	3H,	2	x	bipy,	1	x	phen);	8.21	(t,	2H,	J	=	7.8	Hz,	bipy);	8.29	(d,	
1H,	J	=	1.0	Hz,	phen);	8.35	(d,	1H,	J	=	8.8	Hz,	phen);	8.44	(d,	1H,	J	=	8.8	Hz,	phen);	8.78-8.90	
(m,	5H,	4	x	bipy,	1	x	phen);	9.16	(d,	1H,	J	=	1.0	Hz,	phen).		ESMS:	m/z	=	492.6	[M	–	2PF6]2+,	
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328.7	[M	–	2PF6	+	H]3+.	High	resolution	ESMS:	m/z	=	492.6056	(calculated	for	
[C49H41N9O8Ru]2+,	492.6055).		
Compound	Ru•E2.	A	mixture	of	compound	D	(1.02	g,	0.98	mmol),	(dppf)PdCl2.CH2Cl2	
(0.05	g,	0.06	mmol)	and	CuI	(0.01	g,	0.05	mmol)	dissolved	in	anhydrous	DMF	/	iPr2NH	(6	cm3,	
5:1,	v:v)	was	deoxygenated	with	argon	for	30	minutes.	To	this	was	added	dropwise	a	
solution	of	C	(1.28	g,	2.07	mmol)	in	deoxygenated	anhydrous	DMF	/	iPr2NH	(3	cm3,	5:1,	v:v).	
The	solution	was	stirred	at	room	temperature	for	16	hours	under	argon	before	the	addition	
of	an	additional	portion	of	C	(1.28	g,	2.07	mmol)	in	the	same	deoxygenated	solvent	mixture.	
The	reaction	was	stirred	under	argon	for	24	hours	before	the	solvent	was	removed	under	
reduced	pressure.	The	resulting	brown	solid	was	purified	by	column	chromatography	on	
silica	gel	(200-300	mesh)	with	CH3CN/H2O/sat.	KNO3(aq)	(100:0:0	to	100:4:2,	v:v:v)	as	the	
eluent.	The	solvent	was	then	removed	under	reduced	pressure	and	the	solid	dissolved	in	
CH2Cl2	(30	cm3),	washed	with	an	excess	of	saturated	KPF6(aq)	solution	(20	cm3)	and	
separated.	The	aqueous	layer	was	extracted	with	further	portions	of	CH2Cl2	(2	x	15	cm3)	and	
the	combined	organic	layers	then	washed	with	water	(2	x	15	cm3),	dried	(MgSO4)	and	the	
solvent	removed	under	reduced	pressure.	Further	purification	was	then	achieved	by	size	
exclusion	chromatography	on	Sephadex®	LH-20	in	CH3OH.	The	solvent	was	removed	under	
reduced	pressure	to	afford	Ru•E2	(0.94	g,	45	%)	as	a	dark	red	solid.	1H	NMR	(400	MHz,	d6-
acetone):	δ	=	1.45	(br	s,	72H,	tBu);	3.49	(br	s,	16H,	N–CH2–ester);	3.99	(br	s,	8H,	CH2-pyridyl);	
7.40-7.45	(m,	2H,	bipy);	7.56	(s,	4H,	pyridyl	H3/H5);	7.60-7.66	(m,	2H,	bipy);	8.05	(d,	2H,	J	=	
5.6	Hz,	bipy);	8.12-8.21	(m,	4H,	bipy);	8.25	(t,	2H,	J	=	7.9	Hz,	bipy);	8.48	(s,	2H,	phen);	8.67	(d,	
2H,	J	=	1.9	Hz,	phen);	8.85	(m,	4H,	bipy);	9.05	(d,	2H,	J	=	1.9	Hz,	phen).	ESMS:	m/z	=	912.4	[M	
–	2PF6]2+,	608.6	[M	–	2PF6	+	H]3+.	High	resolution	ESMS:	m/z	=	912.4073	(calculated	for	
[C98H122N12O16Ru]2+,	912.4067).	
Compound	Ru•L2.	A	solution	of	Ru•E2	(92	mg,	0.044	mmol)	in	CH2Cl2	(3	cm3)	and	TFA	
(3	cm3)	was	stirred	at	room	temperature	for	18	hours.	The	solvent	was	then	removed	under	
reduced	pressure	to	yield	a	red	solid.	This	was	purified	and	isolated	exactly	as	described	for	
Ru•L	(above)	and	dried	under	a	stream	of	N2	to	yield	Ru•L2	(71	mg,	98	%)	as	a	red	solid.	1H	
NMR	(400	MHz,	D2O):	δ	=	4.16	(br	s,	16H,	N–CH2–acid);	4.74	(br	s,	8H,	CH2-pyridyl);	7.17-
7.31	(br	m,	2H,	bipy)	7.37-7.48	(br	m,	2H,	bipy);	7.65	(br	d,	2H,	J	=	4.0	Hz,	bipy);	7.69	(br	s,	
4H,	pyridyl	H3/H5);	7.90	(br	d,	2H,	J	=	4.8	Hz,	bipy);	7.98-8.06	(br	m,	2H,	bipy);	8.06-8.16	(br	
m,	2H,	bipy);	8.25	(br	s,	2H,	phen);	8.35	(br	s,	2H,	phen);	8.51-8.63	(br	m,	4H,	bipy);	8.74	(br	
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s,	2H,	phen).	ESMS:	m/z	=	688.2	[M	–	2PF6]2+.	High	resolution	ESMS:	m/z	=	688.1568	
(calculated	for	[C66H58N12O16Ru]2+,	688.1563).	
Compound	Ru•Gd.	To	a	solution	of	Ru•L	(45	mg,	0.035	mmol)	in	water	(3	cm3)	at	0	
°C	was	added	dropwise	a	solution	of	GdCl3.6H2O	(14	mg,	0.038	mmol)	in	water	(0.5	cm3);	
the	mixture	was	stirred	and	allowed	to	reach	room	temperature.	After	1	hour	the	solution	
was	adjusted	to	pH	5-6	using	a	solution	of	NaOH(aq)	(1M)	and	was	then	left	to	stir	at	room	
temperature	for	a	further	18	hours.	Saturated	KPF6(aq)	solution	was	then	added	to	produce	a	
red	precipitate	(hexafluorophosphate	salt	of	mono-cationic	Ru•Gd)	which	was	filtered	and	
washed	with	water.	This	red	solid	was	dissolved	in	the	minimum	amount	of	CH3OH	and	
precipitated	with	an	excess	of	diethyl	ether.	The	precipitate	was	collected	by	centrifugation	
and	purified	further	using	Sephadex®	LH-20	with	CH3OH.	The	solvent	was	removed	under	
reduced	pressure	and	the	resulting	red	solid	dried	under	a	stream	of	N2.	Counterion	
exchange	was	then	achieved	using	Dowex®	1x2	chloride	form	(100-200	mesh)	in	water.	The	
aqueous	solution	was	filtered,	the	water	removed	under	reduced	pressure,	and	the	
resulting	solid	dried	under	a	stream	of	N2	to	yield	Ru•Gd	(chloride	salt;	35	mg,	84	%)	as	a	red	
solid.	ESMS:	m/z	=	570.1	[M	–	Cl	+	H]2+,	380.4	[M	–	Cl	+	2H]3+.	High	resolution	ESMS:	m/z	=	
570.0562	(calculated	for	[C49H37N9O8RuGd	+	H]2+,	570.0558).	
Compound	Ru•Gd2	was	prepared	using	the	same	method	as	described	above	for	
Ru•Gd,	from	Ru•L2	(100	mg,	0.060	mmol)	and	GdCl3.6H2O	(59	mg,	0.159	mmol)	in	water,	
but	without	the	counter-ion	exchange	step	as	Ru•Gd2	is	neutral.	At	the	end	of	the	reaction	
the	solution	was	purified	by	chromatography	on	Sephadex®	LH-20	with	water.	Evaporation	
of	the	solvent	afforded	Ru•Gd2	(70	mg,	69	%	yield)	as	a	red	solid.	ESMS:	m/z	=	842.1	[M	+	
2H]2+,	852.5	[M	+	Na	+	H]2+,	864.6	[M	+	2Na]2+.	High	resolution	ESMS:	m/z	=	842.5664	
(calculated	for	[C66H50N12O16RuGd2+2H]2+,	842.5530).		
Compound	Ru•Nd.	A	solution	of	Ru•L	(15	mg,	0.012	mmol)	in	water	(3	cm3)	was	
adjusted	to	pH	5-6	using	NaOH(aq)	(0.1	M).	With	stirring,	a	solution	of	Nd(OTf)3	(11	mg,	0.019	
mmol)	in	water	(0.5	cm3)	was	added	dropwise.	The	mixture	was	stirred	at	room	
temperature	and	the	pH	readjusted	to	5-6	using	NaOH(aq)	(0.1	M)	when	necessary.	After	18	
hours,	a	small	portion	of	Dowex®	1x2	chloride	form	(100-200	mesh)	was	added	and	the	
mixture	stirred	at	room	temperature	for	a	further	24	hours.	The	solution	was	then	filtered,	
concentrated	under	reduced	pressure	and	purified	on	Sephadex®	G-15	eluting	with	water.	
The	solvent	was	removed	under	reduced	pressure	and	the	resulting	solid	dried	under	a	
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stream	of	N2	to	yield	Ru•Nd	(chloride	salt;	13	mg,	95	%)	as	a	red	solid.	ESMS:	m/z	=	563.0	[M	
–	Cl	+	H]2+,	375.7	[M	–	Cl	+	2H]3+.	High	resolution	ESMS:	m/z	=	563.0497	(calculated	for	
[C49H37N9O8102Ru144Nd	+	H]2+,	563.0488).	
Compound	Ru•Yb	was	prepared	in	exactly	the	same	way	as	Ru•Nd,	with	Ru•L	(18	
mg,	0.014	mmol)	and	Yb(OTf)3	(14	mg,	0.023	mmol)	affording	14	mg	(83	%	yield)	of	Ru•Yb	as	
a	red	solid.	ESMS:	m/z	=	578.1	[M	–	Cl	+	H]2+.	High	resolution	ESMS:	m/z	=	578.0632	
(calculated	for	[C49H37N9O8102Ru173Yb	+	H]2+,	578.0632).		
Compound	Ru•Nd2	was	prepared	in	the	same	way	as	for	Ru•Gd2,	with	Ru•L2	(11.4	
mg,	0.007	mmol)	and	Nd(OTf)3	(10	mg,	0.017	mmol)	affording	11	mg	(97	%	yield)	of	Ru•Nd2	
as	a	red	solid	after	purification	on	Sephadex®	G-15	eluting	with	water.	ESMS:	m/z	=	829.0	
[M	+	2H]2+,	553.0	[M	+	3H]3+,	415.0	[M	+	4H]4+.	High	resolution	ESMS:	m/z	=	829.0404	
(calculated	for	[C66H50N12O16102Ru144Nd2	+	2H]2+,	829.0429).	
Compound	Ru•Yb2	was	prepared	in	the	same	way	as	for	Ru•Gd2,	with	Ru•L2	(7.4	
mg,	0.004	mmol)	and	Yb(OTf)3	(7	mg,	0.011	mmol)	affording	7.5	mg	(99	%	yield)	of	Ru•Yb2	
after	purification	on	Sephadex®	G-15	eluting	with	water.	ESMS:	m/z	=	858.1	[M	+	2H]2+,	
572.4	[M	+	3H]3+,	429.5	[M	+	4H]4+.	High	resolution	ESMS:	m/z	=	858.0683	(calculated	for	
[C66H50N12O16102Ru173Yb2	+	2H]2+,	858.0710).	
Compound	Ru•Mn.	To	a	stirred	solution	of	Ru•L	(130	mg,	0.102	mmol)	in	water	(3	
cm3),	adjusted	to	pH	5	–	6	with	NaOH(aq),	was	added	dropwise	a	solution	of	MnCl2.4H2O	(26	
mg,	0.131	mmol)	in	water	(0.5	cm3).	The	mixture	was	stirred	at	room	temperature	and	the	
pH	re-adjusted	to	5	–	6	if	necessary.	After	18	hours	the	reaction	mixture	was	concentrated	
under	reduced	pressure	and	purified	on	Sephadex®	G-15,	eluting	with	water.	The	solvent	
was	removed	under	reduced	pressure	and	the	resulting	red	solid	dried	under	a	stream	of	N2	
to	yield	Ru•Mn	(100	mg,	95	%)	as	a	red	solid.	ESMS:	m/z	=	519.1	[M	+	2H]2+.	High	resolution	
ESMS:	m/z	=	519.0658	(calculated	for	[C49H37N9O8RuMn	+	2H]2+,	519.0674).	
Compound	Ru•Zn.	This	was	prepared	in	exactly	the	same	way	as	Ru•Mn,	from	Ru•L	
(38	mg,	0.03	mmol)	and	ZnCl2.xH2O	(10	mg,	ca.	0.049	mmol)	to	give	Ru•Zn	(25	mg,	80	%)	as	
a	red	solid.	1H	NMR	(400	MHz,	D2O):	δ	=	3.34-3.52	(m,	8H,	NCH2-CO2);	4.15	(s,	4H,	NCH2-
pyridyl);	7.16-7.26	(m,	2H,	bipy);	7.39-7.46	(m,	2H,	bipy);	7.48	(s,	1H,	pyridyl	H3	or	H5);	7.52	
(s,	0.5H,	pyridyl	H3	or	H5);	7.54	(s,	0.5H,	pyridyl	H3	or	H5);	7.58	(d,	1H,	J	=	5.3	Hz,	bipy);	7.68	
(d,	1H,	J	=	5.3	Hz,	bipy);	7.73	(t,	1H,	J	=	6.5	Hz,	phen);	7.91	(d,	1H,	J	=	5.3	Hz,	bipy);	7.94	(d,	
1H,	J	=	5.3	Hz,	bipy);	7.99	(t,	2H,	J	=	7.5	Hz,	bipy);	8.09	(t,	2H,	J	=	7.5	Hz,	bipy);	8.18	(d,	1H,	J	=	
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4.8	Hz,	phen);	8.19-8.29	(m,	2H,	phen);	8.35	(d,	1H,	J	=	4.5	Hz,	phen);	8.50-8.64	(m,	5H,	4	x	
bipy,	1	x	phen);	8.76	(s,	0.5H,	phen);	8.79	(s,	0.5H,	phen).	ESMS:	m/z	=	523.6	[M	+	2H]2+.	
High	resolution	ESMS:	m/z	=	523.5632	(calculated	for	[C49H37N9O8RuMn	+	2H]2+,	523.5626).	
Compound	Ru•Mn2.	This	was	prepared	in	the	same	way	as	Ru•Mn,	from	Ru•L2	(41	
mg,	0.025	mmol)	and	MnCl2•4H2O	(12	mg,	0.061	mmol),	affording	after	purification	
(Sephadex®	G-15,	eluting	with	water)	pure	Ru•Mn2	as	its	disodium	salt	(25	mg,	67	%).	ESMS:	
m/z	=	739.1	[M	–	2Na]2–.	High	resolution	ESMS:	m/z	=	739.0598	(calculated	for	
[C66H50N12O16102RuMn2]2–,	739.0631).	
Compound	Ru•Zn2.	This	was	prepared	in	the	same	way	as	Ru•Zn,	from	Ru•L2	(9	mg,	
5.2	µmol)	and	ZnCl2•xH2O	(10	mg,	ca.	49	µmol),	affording	after	purification	(Sephadex®	G-
15,	eluting	with	water)	pure	Ru•Zn2	as	its	disodium	salt	(7	mg,	82	%).	ESMS:	m/z	=	748.1	[M	
–	2Na]2–.	High	resolution	ESMS:	m/z	=	748.0532	(calculated	for	[C66H50N12O16102Ru64Zn2]2–,	
748.0553).	
	
Computational	Details	
All	calculations	were	performed	with	Gaussian	09	v.	D.0128	using	density-functional	
theory.	The	functional	used	was	B3LYP29	with	empirical	dispersion	corrections	through	the	
GD3BJ	keyword.30		The	basis	set	used	consisted	of	SDD31	on	Ru	or	lanthanide	atoms,	and	6-
311G(d,p)32,33	on	all	other	atoms.	All	bulk	solvent	was	described	using	the	PCM	method34,35	
as	implemented	in	Gaussian	using	the	provided	parameters	for	water.	No	additional	water	
molecules	were	included	to	simulate	hydrogen	bonding.		
All	Ru•Mn	complexes	(and	their	reduced/oxidized	forms)	were	assumed	to	be	in	the	
high-spin	configuration	for	Mn,	where	relevant.	During	the	calculations	it	was	found	that	
there	is	a	large	manifold	of	potential	sextet	states	for	Ru•Mn.		Different	starting	geometries	
will	lead	to	different	final	electronic	states	for	a	similar	final	geometry	with	the	pyridine	
fragment	of	the	Mn(II)	moiety	co-planar	with	the	phen	fragment	of	the	Ru(II)	moiety.	In	fact,	
the	lowest	sextet	energies	were	obtained	by	starting	from	a	geometry	in	which	the	pyridine	
fragment	of	the	Mn(II)	moiety	is	perpendicular	to	the	phen	fragment	of	the	Ru(II)	fragment,	
i.e.	through	restricting	the	size	of	the	conjugated	system.		Coupling	between	the	excited-
state	(3MLCT)	Ru(II)	and	ground-state	Mn(II)	moieties	was	assumed	to	be	weakly	anti-
ferromagnetic	upon	excitation:	preliminary	calculations	on	the	octet	state	(which	would	
arise	from	ferromagnetic	coupling)	of	photo-excited	Ru•Mn	all	show	a	higher	energy	than	
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the	corresponding	quartet	states.		For	all	optimised	structures	frequencies	were	calculated	
in	the	harmonic	approximation.	Only	small	imaginary	frequencies	(<	15	cm−1)	were	found.	
These	molecules	were	considered	to	be	true	minima,	since	such	small	imaginary	values	are	
commonly	associated	with	errors	in	the	integration	grids	used.		
All	absorption	spectra	were	calculated	with	the	TD-DFT	method36	as	implemented	in	
G09.		All	images	were	created	with	in-house	developed	software,	which	is	available	upon	
request.	The	overlays	were	created	using	ROCS.37,38	Finally,	the	computational	ESI	was	
created	using	in-house	developed	software	based	on	the	Open	Eye	Toolkit.39		
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Scheme	1:	Previously-reported	Ir(III)/Ln(III)	complexes	based	on	a	bridging	ligand	skeleton	
combining	phenanthroline	and	polyaminocarboxylate	binding	sites	for	the	Ir(III)	and	Ln(III)	
metal	centres,	respectively,	connected	by	an	alkyne	spacer	(see	ref.	6).	
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Scheme	2.		Preparation	of	Ru•E,	Ru•L	and	heterodinuclear	complexes	Ru•M.	
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Scheme	3.	Preparation	of	ester-protected	alkyne	intermediate	C	(used	in	Schemes	2	and	4)	
	 	
N NN CO2
tBu
CO2tButBuO2C
tBuO2C
C
N NN CO2
tBu
CO2tButBuO2C
tBuO2C
CSi
SiMe3
N
Br
NN CO2tBu
CO2tButBuO2C
tBuO2C
B
TMS-CCH / Pd(PPh3)2Cl2 /
CuI / iPr2NH
Bu4NF / THF
	 43	
		
	
Scheme	4.		Preparation	of	Ru•E2,	Ru•L2	and	heterotrinuclear	complexes	Ru•M2.	
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Table	1.		UV/Vis	absorption	and	luminescence	data	for	the	new	mononuclear	Ru(II)	
complexes.	
	
	 labsRT	/	nm	
[103	e /	M-1	cm-1]a	
lemRT	/	nm		
[t /	ns]a	
lem77K	/	nm		
[t /	µs]b	
Ru•E	 286	[88],	321	(sh)	[39],	444	
(br)	[14]	
647	[240]	 611,	660	(sh),	711(sh)	[6.2]	
Ru•L	 285	[120],	325	(sh)	[55],	
442	(br)	[16]	
661	[340]	 611,	662	(sh),	706	(sh)	
[5.8]	
Ru•E2	 351	[56],	437	[14],	476	(sh)	
[10].	
683	[271]	 645,	701	(sh)	[3.8]	
Ru•L2	 349	[46],	434	[6.5],	485	
(sh)	[3.7]	
697	[209,	102]	 Not	soluble	
a	 Absorption	and	emission	spectra	at	RT	measured	in	MeCN	(Ru•E	and	Ru•E2)	or	
water	(Ru•L	and	Ru•L2).		Estimated	uncertainty	in	lifetimes	is	±10%	for	single	
component	decays.	
b	 Emission	spectra	at	77	K	measured	in	EtOH/MeOH	(4:1,	v/v)	glass	
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Table	2.		UV/Vis	absorption	and	luminescence	data	for	the	Ru/M	heterometallic	complexes	
(M	=	Gd,	Mn,	Zn).	
	
	 labsRT	/	nm	
[103	e /	M-1	cm-1]a	
lemRT	/	nm		
[t /	ns]a	
lem77K	/	nm		
[t /	µs]b	
Ru•Gd	 286	[56],	326	(sh)	[25],	443	
(br)	[7.5]	
664	[351]	 612,	662	(sh),	706	
(sh)	[5.3]	
Ru•Gd2	 286	[99],	350	[74],	435	[11],	
486	(sh)	[5.9]	
699	[402,	104]	 not	soluble	
Ru•Mn	 285	[80],	325	(sh)	[34],	441	
(br)	[10]	
657	[410,	91]	 612,	660,	709	[1.8,	
0.45]	
Ru•Mn2	 286	[86],	350	[59],	435	[7.9],	
481	(sh)	[4.4]	
700	[456,	164,	21]	 not	soluble	
Ru•Zn	 285	[80],	326	(sh)	[34],	440	
(br)	[10]	
666	[329]	 617,	668,	720	[5.6]	
Ru•Zn2	 285	[88],	348	[55],	435	[9.2],	
478	(sh)	[5.3]	
695	[301,	117]	 not	soluble	
a	 Absorption	and	emission	spectra	at	RT	measured	in	water.		Estimated	uncertainty	in	
lifetimes	is	±10%	for	single	component	decays.	
b	 Emission	spectra	at	77	K	measured	in	EtOH/MeOH	(4:1,	v/v)	glass.	
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Table	3.		Luminescence	data	for	the	Ru/Yb	and	Ru/Nd	heterometallic	complexes.	
	
	 lemRT	/	nm	[t /	ns]	in	H2O	
for	Ru(II)	emission	a	
lemRT	/	nm	[t /	µs]	in	D2O	
for	Ln(III)	emission	
Ru•Yb	 663	[242,	73]	 980	[13]	
Ru•Yb2	 700	[223,	88]	 980	[10.5,	0.3]	b	
Ru•Nd	 662	[358,	22]	 1060,	1380	[0.8]	
Ru•Nd2	 703	[408,	18]	 1060,	1380	[0.7]	
a			 Two	Ru(II)-based	luminescence	components:	the	shorter	one	is	assumed	to	be	associated	
	 with	maximum	quenching	by	the	lanthanide	(see	main	text).	
b	 The	shorter	luminescence	component	detected	at	980	nm	is	from	the	tail	of	unquenched	
Ru(II)-based	emission	which	overlaps	with	the	Yb(III)-based	emission.	
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Fig.	1.			 Normalised,	corrected	luminescence	spectra	of	the	four	mononuclear	Ru(II)	
complexes	in	aerated	EtOH/MeOH	(4:1,	v/v)	at	298	K	and	in	a	glass	at	77	K,	
excitation	wavelength	435	nm.		
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Fig.	2.	 Corrected	luminescence	spectra	in	water	at	RT	showing	the	Ru(II)-based	
luminescence	of	the	three	dinuclear	Ru•Ln	and	three	trinuclear	Ru•Ln2	complexes	
(Ln	=	Gd,	Yb,	Nd);	all	solutions	were	isoabsorbing	at	the	excitation	wavelength	(lexc	
=	430	nm).	
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Fig.	3.	 Corrected	luminescence	spectra	in	D2O	at	298	K	in	the	near-infrared	region,	
showing	the	sensitised	lanthanide-based	luminescence	from	the	complexes	Ru•Yb2	
and	Ru•Nd2	complexes	(lexc	=	440	nm	for	both	spectra).	
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Fig.	4.	 Corrected	luminescence	spectra	in	water	at	298	K	for	the	four	Ru/Mn	and	Ru/Zn	
complexes;	all	solutions	were	isoabsorbing	at	the	excitation	wavelength	(lexc	=	435	
nm).	
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Fig.	5.	 Top:	differential	transient	absorption	spectra	in	air-equilibrated	water	of	Ru•Zn	at	
a	range	of	different	time	delays	following	excitation	(lexc	=	400	nm,	40	fs,	3	mW	
pulse).		Bottom:	dynamics	of	the	transient	signals	over	a	5	ns	period.	
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Fig.	6.	 Top:	differential	transient	absorption	spectra	in	air-eqilibrated	water	of	Ru•Mn	at	a	
range	of	different	time	delays	following	excitation	(lexc	=	400	nm,	40	fs,	3	mW	
pulse).		The	small	sharp	feature	at	400	nm	is	scattering	of	the	pump	light.	Bottom:	
dynamics	of	the	transient	signals	over	a	5	ns	period.	
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Fig.	7.			 Results	of	computational	studies	on	Ru•Mn.		(a)	Optimized	structure	for	Ru•Mn	in	
its	sextet	ground	state.			(b)	Spin	density	for	Ru•Mn	in	its	ground	state	sextet	state	
(isosurface	at	density	=	0.0004;	blue	=	a-spin,	red	=	b-spin).		(c)	Spin	density	for	
Ru•Mn	in	its	lowest	excited	quartet	state	(isosurface	at	density=0.0004,	blue	=	a-
spin,	green	=	b-spin).	(d)	Spin	density	for	Ru•Mn	in	lowest	excited	quartet	state	
(isosurface	at	density	=	0.0004,	blue	=	a-spin,	red	=	b-spin)	with	rotated	pyridyl	unit	
at	90°	to	the	phenanthroline	unit.		(e)	Difference	density	for	Ru•Mn	between	
neutral	and	mono-oxidised	form	(isosurface	at	density	=	0.0004,	green	=	increase,	
purple	=	decrease).	(f)	Difference	density	for	Ru•Mn	between	mono-reduced	and	
neutral	form	(isosurface	at	density	=	0.0004,	green	=	increase,	purple	=	decrease)	
with	rotated	pyridyl	unit	at	90°	to	the	phenanthroline	unit.	
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Fig.	8	 Overlays	of	the	neutral	form	of	Ru•Mn	with	other	forms	accessed	in	the	
computational	experiments.		In	all	panels,	the	neutral	form	of	Ru•Mn	is	shown	in	
the	majority	grey	colour,	the	other	form	being	compared	to	is	shown	in	green.	(a)	
Overlay	of	Ru•Mn	in	its	‘planar’	form,	with	the	‘perpendicular’	form	arising	from	
twisting	the	pyridyl	group	with	respect	to	the	phen	group.	(b)	Overlay	of	Ru•Mn	(6A	
ground	state)	with	Ru•Mn	(4A	excited	state):	the	significant	change	in	geometry	
around	the	Mn	centre	indicates	its	transient	oxidation	to	Mn(III).	(c)	Overlay	of	
[Ru•Mn]0	(6A)	with	[Ru•Mn]+	(5A):	the	significant	change	in	geometry	around	the	
Mn	centre	indicates	its	oxidation	to	Mn(III).	(d)	Overlay	of	[Ru•Mn]0	(6A)	with	
[Ru•Mn]–	(5A):	the	lack	of	significant	changes	in	coordination	geometry	around	
either	metal	ion	is	consistent	with	a	phen-based	reduction.	
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Fig.	9	 Simulated	UV-VIS	spectrum	for	Ru•Mn.	The	stick	spectrum	(green	lines)	indicates	
the	transitions	as	calculated	by	TD-DFT	with	their	calculated	oscillator	strengths.	
The	simulated	full	spectrum	is	generated	using	Gaussian	shapes	with	a	FWHM	of	
1500	cm-1;	this	may	be	compared	with	the	real	spectrum	in	SI.	
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Fig.	10.	 Confocal	microscopy	images	of	HeLa	cells	incubated	with	(a)	Ru•Gd	or	(b)	Ru•Gd2	
(50	µM,	4h	incubation	in	each	case).	lexc	=	405	nm;	lem	=	570	–	620	nm.	Scale	bars	
=	20	µm.	
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Heteronuclear	d-d	and	d-f	Ru(II)/M	complexes	[M	=	Gd(III),	Yb(III),	Nd(III),	
Zn(II)	or	Mn(II)]	of	ligands	combining	phenanthroline	and	aminocarboxylate	
binding	sites:	combined	relaxivity,	cell	imaging	and	photophysical	studies.	
	
Table	of	Contents	entry	
	
	
	
A	series	of	complexes	in	which	a	phosphorescent	[Ru(NN)3]2+	core	is	attached	to	one	or	two	
pendant	f-block	[Gd(III),	Nd(III),	Yb(III)]	or	d-block	[Mn(II),	Zn(II)]	ions	have	been	studied	for	
their	relaxivity	and	cell	imaging	properties,	and	photophysical	properties	which	include	Ru-
to-lanthanide	photoinduced	energy-transfer	and	Mn-to-Ru	photoinduced	electron	transfer.	
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